<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:e5d0f0b2-28f0-402b-8ff5-56208266c5ea,g:67c8cf01-c06c-4e46-bd53-697f2af788ac-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.x4pharma.com/role/CoverPage" xlink:type="simple" xlink:href="xfor-20240331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d07abd7e-8791-43f9-a599-d4f317c98c03" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_DocumentType_d07abd7e-8791-43f9-a599-d4f317c98c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_36dd6888-fe69-4020-a0b3-92eba916f0b5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_DocumentQuarterlyReport_36dd6888-fe69-4020-a0b3-92eba916f0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e100358d-f1e7-4d74-adce-0d1460c4b41e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_DocumentPeriodEndDate_e100358d-f1e7-4d74-adce-0d1460c4b41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5861014d-3712-4a41-a418-218bec3de828" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_DocumentTransitionReport_5861014d-3712-4a41-a418-218bec3de828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_24157c2f-b0d6-4ea6-9ab0-bdd5b5029659" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityFileNumber_24157c2f-b0d6-4ea6-9ab0-bdd5b5029659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_1d8c10d7-3b1b-493f-844a-bb1aee497537" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityRegistrantName_1d8c10d7-3b1b-493f-844a-bb1aee497537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ac29eb6f-bafd-4586-9ee8-b22ca6ca280f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ac29eb6f-bafd-4586-9ee8-b22ca6ca280f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_780e35a3-7bb8-4460-bfa5-09576672c244" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityTaxIdentificationNumber_780e35a3-7bb8-4460-bfa5-09576672c244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_8effeb39-005d-4ae5-b6e4-800c9a0bb9d5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityAddressAddressLine1_8effeb39-005d-4ae5-b6e4-800c9a0bb9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_843acf63-c299-4b85-9644-a28f94476fe2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityAddressAddressLine2_843acf63-c299-4b85-9644-a28f94476fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1b5fae0e-9d4f-4c3b-b9da-cb2e155d7bcd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityAddressCityOrTown_1b5fae0e-9d4f-4c3b-b9da-cb2e155d7bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_31031543-be2c-4f95-8be7-6637c28fd9cf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityAddressStateOrProvince_31031543-be2c-4f95-8be7-6637c28fd9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_39a0ac13-e355-4058-b27f-e6cc20bfd0c5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityAddressPostalZipCode_39a0ac13-e355-4058-b27f-e6cc20bfd0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_38065be2-c346-4009-9756-995cd70e8896" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_CityAreaCode_38065be2-c346-4009-9756-995cd70e8896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_91623727-4b88-477e-86b0-1e29c6ee0504" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_LocalPhoneNumber_91623727-4b88-477e-86b0-1e29c6ee0504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_dfc2b22e-4c2b-436e-bdf8-6b0e56a13044" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_Security12bTitle_dfc2b22e-4c2b-436e-bdf8-6b0e56a13044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2e8b8d0e-54e9-421f-9303-7f7fd7d3a962" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_TradingSymbol_2e8b8d0e-54e9-421f-9303-7f7fd7d3a962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_958d42c7-8c01-499f-881a-6169c86abbb9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_SecurityExchangeName_958d42c7-8c01-499f-881a-6169c86abbb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_0d2dfb88-2656-4112-a854-161ca6feb95f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityCurrentReportingStatus_0d2dfb88-2656-4112-a854-161ca6feb95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_a1291307-9b55-497e-aba2-a76cc02dabf5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityInteractiveDataCurrent_a1291307-9b55-497e-aba2-a76cc02dabf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_573e25a3-b2ee-4cff-8929-7e7f630e7701" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityFilerCategory_573e25a3-b2ee-4cff-8929-7e7f630e7701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_bc8ba937-aa6f-4390-a8ff-f6ab5251632a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntitySmallBusiness_bc8ba937-aa6f-4390-a8ff-f6ab5251632a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_bff7a1f2-1394-4cbf-987e-d1c1220cc065" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityEmergingGrowthCompany_bff7a1f2-1394-4cbf-987e-d1c1220cc065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_37675288-34d9-4792-8261-3eabb92ab760" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityShellCompany_37675288-34d9-4792-8261-3eabb92ab760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_50a53c71-3bde-43fa-9828-b5de0eb89ecc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_50a53c71-3bde-43fa-9828-b5de0eb89ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c634ca5a-c797-400d-ad85-1a8ad83966f0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_AmendmentFlag_c634ca5a-c797-400d-ad85-1a8ad83966f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7f46e05d-c21e-4f1e-a802-d3f61883ca83" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_DocumentFiscalYearFocus_7f46e05d-c21e-4f1e-a802-d3f61883ca83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_cf9ed0fd-6d0b-4f9c-a3d3-c5aab36a8c1e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_cf9ed0fd-6d0b-4f9c-a3d3-c5aab36a8c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_05f6d2c5-c45a-4048-9c2c-a031265708c5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_EntityCentralIndexKey_05f6d2c5-c45a-4048-9c2c-a031265708c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_2145980e-c7ce-4ea9-a85f-cf84eed7e6a7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_84f246b4-556d-408d-af5a-78a55262941e" xlink:to="loc_dei_CurrentFiscalYearEndDate_2145980e-c7ce-4ea9-a85f-cf84eed7e6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="xfor-20240331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e839b08f-8af5-4df7-a5e5-9ceff74ae0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9030b159-eb3c-4215-814c-ad51c3dffa8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e839b08f-8af5-4df7-a5e5-9ceff74ae0f7" xlink:to="loc_us-gaap_AssetsAbstract_9030b159-eb3c-4215-814c-ad51c3dffa8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_9499d875-591d-4115-bbbf-f64d4914996b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9030b159-eb3c-4215-814c-ad51c3dffa8d" xlink:to="loc_us-gaap_AssetsCurrentAbstract_9499d875-591d-4115-bbbf-f64d4914996b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_90fbb6e9-5a26-4b3b-9291-634d7f25aa70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9499d875-591d-4115-bbbf-f64d4914996b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_90fbb6e9-5a26-4b3b-9291-634d7f25aa70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_be616dd1-a213-4929-9017-23ea3863f7db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9499d875-591d-4115-bbbf-f64d4914996b" xlink:to="loc_us-gaap_MarketableSecurities_be616dd1-a213-4929-9017-23ea3863f7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ResearchAndDevelopmentIncentiveReceivable_3b68c24e-3000-48ed-b68c-e357ade5cea0" xlink:href="xfor-20240331.xsd#xfor_ResearchAndDevelopmentIncentiveReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9499d875-591d-4115-bbbf-f64d4914996b" xlink:to="loc_xfor_ResearchAndDevelopmentIncentiveReceivable_3b68c24e-3000-48ed-b68c-e357ade5cea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_080da57c-2bdc-42df-ab0e-a16e1f9f8bda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9499d875-591d-4115-bbbf-f64d4914996b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_080da57c-2bdc-42df-ab0e-a16e1f9f8bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_da4abd7f-ad2e-4055-b2c2-24661b4acef6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9499d875-591d-4115-bbbf-f64d4914996b" xlink:to="loc_us-gaap_AssetsCurrent_da4abd7f-ad2e-4055-b2c2-24661b4acef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_71535bfe-52ff-419d-a27c-f1529a471fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9030b159-eb3c-4215-814c-ad51c3dffa8d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_71535bfe-52ff-419d-a27c-f1529a471fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cba78f44-ad15-4d8d-b793-5d7187f71dca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9030b159-eb3c-4215-814c-ad51c3dffa8d" xlink:to="loc_us-gaap_Goodwill_cba78f44-ad15-4d8d-b793-5d7187f71dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e38204c3-33fc-44c7-bf25-7bb3c55ca4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9030b159-eb3c-4215-814c-ad51c3dffa8d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e38204c3-33fc-44c7-bf25-7bb3c55ca4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3a155a4d-7f34-425b-aeda-a11e9223b243" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9030b159-eb3c-4215-814c-ad51c3dffa8d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3a155a4d-7f34-425b-aeda-a11e9223b243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c1557057-be12-4822-9c4c-c22a16431656" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9030b159-eb3c-4215-814c-ad51c3dffa8d" xlink:to="loc_us-gaap_Assets_c1557057-be12-4822-9c4c-c22a16431656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f7d04c06-10de-4ae3-8547-8756cfd8ef1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e839b08f-8af5-4df7-a5e5-9ceff74ae0f7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f7d04c06-10de-4ae3-8547-8756cfd8ef1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9022e16b-c071-4f4d-a267-003d7d449fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f7d04c06-10de-4ae3-8547-8756cfd8ef1e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9022e16b-c071-4f4d-a267-003d7d449fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c3d6a78b-ef9f-4230-add0-87db6c27ae68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9022e16b-c071-4f4d-a267-003d7d449fb2" xlink:to="loc_us-gaap_AccountsPayableCurrent_c3d6a78b-ef9f-4230-add0-87db6c27ae68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3f14ce35-b484-4de9-9f8f-f550c9127884" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9022e16b-c071-4f4d-a267-003d7d449fb2" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3f14ce35-b484-4de9-9f8f-f550c9127884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_245ad630-b3ca-4e45-bfdc-fcac02c47cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9022e16b-c071-4f4d-a267-003d7d449fb2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_245ad630-b3ca-4e45-bfdc-fcac02c47cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9cf0ea4b-0787-41bf-abb3-e02f113dda86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9022e16b-c071-4f4d-a267-003d7d449fb2" xlink:to="loc_us-gaap_LiabilitiesCurrent_9cf0ea4b-0787-41bf-abb3-e02f113dda86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LongTermDebtNonCurrentIncludingAccretion_4f6e73b6-e846-4ea5-822b-943841b767b4" xlink:href="xfor-20240331.xsd#xfor_LongTermDebtNonCurrentIncludingAccretion"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f7d04c06-10de-4ae3-8547-8756cfd8ef1e" xlink:to="loc_xfor_LongTermDebtNonCurrentIncludingAccretion_4f6e73b6-e846-4ea5-822b-943841b767b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6caf192e-f67b-40bf-b3c1-797d366292d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f7d04c06-10de-4ae3-8547-8756cfd8ef1e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6caf192e-f67b-40bf-b3c1-797d366292d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_baeb57d6-89ed-41ed-933b-e9b767e6fe83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f7d04c06-10de-4ae3-8547-8756cfd8ef1e" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_baeb57d6-89ed-41ed-933b-e9b767e6fe83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7f1bd74e-e2fc-47db-895e-35b8e59d3b20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f7d04c06-10de-4ae3-8547-8756cfd8ef1e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7f1bd74e-e2fc-47db-895e-35b8e59d3b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_910b5838-41b9-42ba-b2ed-3034e0839da2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f7d04c06-10de-4ae3-8547-8756cfd8ef1e" xlink:to="loc_us-gaap_Liabilities_910b5838-41b9-42ba-b2ed-3034e0839da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_6e06a433-65b4-4155-87d5-b4b85065a4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f7d04c06-10de-4ae3-8547-8756cfd8ef1e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_6e06a433-65b4-4155-87d5-b4b85065a4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_fe04439e-09f1-461f-a131-65b064428934" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f7d04c06-10de-4ae3-8547-8756cfd8ef1e" xlink:to="loc_us-gaap_StockholdersEquityAbstract_fe04439e-09f1-461f-a131-65b064428934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d9e33549-e0d5-4c7f-924a-b633fd54a9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe04439e-09f1-461f-a131-65b064428934" xlink:to="loc_us-gaap_CommonStockValue_d9e33549-e0d5-4c7f-924a-b633fd54a9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9155c24c-57ad-4b9b-a9c5-6b3b9ce546bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe04439e-09f1-461f-a131-65b064428934" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9155c24c-57ad-4b9b-a9c5-6b3b9ce546bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fdefe5b1-e184-451f-b700-9fe377d8c520" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe04439e-09f1-461f-a131-65b064428934" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fdefe5b1-e184-451f-b700-9fe377d8c520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_739e7ae4-6967-4323-9da6-61be0af9a7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe04439e-09f1-461f-a131-65b064428934" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_739e7ae4-6967-4323-9da6-61be0af9a7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1cdd96fd-6565-4989-a5c9-fc92a5e1e8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe04439e-09f1-461f-a131-65b064428934" xlink:to="loc_us-gaap_StockholdersEquity_1cdd96fd-6565-4989-a5c9-fc92a5e1e8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_6c114cc9-5a4c-431b-91df-4bf069b8ebed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f7d04c06-10de-4ae3-8547-8756cfd8ef1e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_6c114cc9-5a4c-431b-91df-4bf069b8ebed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="xfor-20240331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_fecd33ee-819a-43c7-8ce1-ff4f04d1159c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c322b89a-ff9a-437d-b61a-c9c18cc1b314" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fecd33ee-819a-43c7-8ce1-ff4f04d1159c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c322b89a-ff9a-437d-b61a-c9c18cc1b314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_e2da1b98-9619-4d87-874e-1fbe68ac4b97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fecd33ee-819a-43c7-8ce1-ff4f04d1159c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_e2da1b98-9619-4d87-874e-1fbe68ac4b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_9b5215b1-82d7-4e70-a9a0-6ab35691c25d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fecd33ee-819a-43c7-8ce1-ff4f04d1159c" xlink:to="loc_us-gaap_CommonStockSharesIssued_9b5215b1-82d7-4e70-a9a0-6ab35691c25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_914a4b69-3c65-459c-bffb-60626d676304" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fecd33ee-819a-43c7-8ce1-ff4f04d1159c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_914a4b69-3c65-459c-bffb-60626d676304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="xfor-20240331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_f3f6b0db-ac0b-482e-bd2b-d70e17ecba37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6a8b2d89-c824-4aaf-a182-53b84b7da880" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f3f6b0db-ac0b-482e-bd2b-d70e17ecba37" xlink:to="loc_us-gaap_StatementTable_6a8b2d89-c824-4aaf-a182-53b84b7da880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_5d9a7125-ffe9-45a4-962c-811b128371ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6a8b2d89-c824-4aaf-a182-53b84b7da880" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_5d9a7125-ffe9-45a4-962c-811b128371ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10f75c4a-a98b-47ba-9557-64d78470fa4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_5d9a7125-ffe9-45a4-962c-811b128371ea" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10f75c4a-a98b-47ba-9557-64d78470fa4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_69683b06-cc7b-4a6f-b498-f7e9c9ea7fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10f75c4a-a98b-47ba-9557-64d78470fa4a" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_69683b06-cc7b-4a6f-b498-f7e9c9ea7fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_WarrantLiabilityMember_098305b1-b1de-4649-af9c-2d39251cb421" xlink:href="xfor-20240331.xsd#xfor_WarrantLiabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10f75c4a-a98b-47ba-9557-64d78470fa4a" xlink:to="loc_xfor_WarrantLiabilityMember_098305b1-b1de-4649-af9c-2d39251cb421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_595df947-c5f4-47f3-85dc-d1e94be53419" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6a8b2d89-c824-4aaf-a182-53b84b7da880" xlink:to="loc_us-gaap_StatementLineItems_595df947-c5f4-47f3-85dc-d1e94be53419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_c12a2bad-c9ad-43a1-b9b6-e5377faf366d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_595df947-c5f4-47f3-85dc-d1e94be53419" xlink:to="loc_us-gaap_OperatingExpensesAbstract_c12a2bad-c9ad-43a1-b9b6-e5377faf366d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d617cab2-7c38-46d9-b7cc-f3f6d834ae87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c12a2bad-c9ad-43a1-b9b6-e5377faf366d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d617cab2-7c38-46d9-b7cc-f3f6d834ae87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_518a311a-57fd-4ee1-9acb-39750121598d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c12a2bad-c9ad-43a1-b9b6-e5377faf366d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_518a311a-57fd-4ee1-9acb-39750121598d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0e587e87-f5c9-4d22-a605-586f6a22de29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_c12a2bad-c9ad-43a1-b9b6-e5377faf366d" xlink:to="loc_us-gaap_OperatingExpenses_0e587e87-f5c9-4d22-a605-586f6a22de29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7e72595c-f25f-423e-b4c3-c9dab5d21b91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_595df947-c5f4-47f3-85dc-d1e94be53419" xlink:to="loc_us-gaap_OperatingIncomeLoss_7e72595c-f25f-423e-b4c3-c9dab5d21b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a382d25e-a6c1-4652-a9e1-8333d8ab8c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_595df947-c5f4-47f3-85dc-d1e94be53419" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a382d25e-a6c1-4652-a9e1-8333d8ab8c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_018bcaa5-eb33-44fb-bcfa-f812624d9d66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a382d25e-a6c1-4652-a9e1-8333d8ab8c0a" xlink:to="loc_us-gaap_InvestmentIncomeInterest_018bcaa5-eb33-44fb-bcfa-f812624d9d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_876b457a-7fe7-49f1-bc68-2ccffe3043a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a382d25e-a6c1-4652-a9e1-8333d8ab8c0a" xlink:to="loc_us-gaap_InterestExpense_876b457a-7fe7-49f1-bc68-2ccffe3043a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_34a3a933-f3b9-4145-a5bf-e1333f1bce6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a382d25e-a6c1-4652-a9e1-8333d8ab8c0a" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_34a3a933-f3b9-4145-a5bf-e1333f1bce6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_db0afdd9-a7d5-4931-ba29-62b562cdf450" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a382d25e-a6c1-4652-a9e1-8333d8ab8c0a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_db0afdd9-a7d5-4931-ba29-62b562cdf450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1db604c0-dec7-406e-8a41-d30918e5155a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_a382d25e-a6c1-4652-a9e1-8333d8ab8c0a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1db604c0-dec7-406e-8a41-d30918e5155a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_95d1433a-974d-48a5-8feb-6b77cd8e4410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_595df947-c5f4-47f3-85dc-d1e94be53419" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_95d1433a-974d-48a5-8feb-6b77cd8e4410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f39680a0-8bee-4a23-8a30-3019ed7a026f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_595df947-c5f4-47f3-85dc-d1e94be53419" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f39680a0-8bee-4a23-8a30-3019ed7a026f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_012473c7-8b0a-4180-8c2f-0409ee654a82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_595df947-c5f4-47f3-85dc-d1e94be53419" xlink:to="loc_us-gaap_NetIncomeLoss_012473c7-8b0a-4180-8c2f-0409ee654a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1725fa38-5fde-445a-8a0e-50ae09741ded" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_595df947-c5f4-47f3-85dc-d1e94be53419" xlink:to="loc_us-gaap_EarningsPerShareBasic_1725fa38-5fde-445a-8a0e-50ae09741ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a4c9d1d1-e513-4c5c-b6ca-f367ac63c574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_595df947-c5f4-47f3-85dc-d1e94be53419" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a4c9d1d1-e513-4c5c-b6ca-f367ac63c574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f5426512-c6fc-4008-b5f1-ebbda94d423e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_595df947-c5f4-47f3-85dc-d1e94be53419" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f5426512-c6fc-4008-b5f1-ebbda94d423e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7b9672ed-a944-4459-9ceb-41194e010577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_595df947-c5f4-47f3-85dc-d1e94be53419" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7b9672ed-a944-4459-9ceb-41194e010577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_3daebb1d-d6b0-4583-81c4-77627074c9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalIncomeStatementElementsAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_595df947-c5f4-47f3-85dc-d1e94be53419" xlink:to="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_3daebb1d-d6b0-4583-81c4-77627074c9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_TemporaryEquityRepurchaseOfConvertiblePreferredStock_f7964b65-9681-4fc9-b665-a4dc731615bb" xlink:href="xfor-20240331.xsd#xfor_TemporaryEquityRepurchaseOfConvertiblePreferredStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_3daebb1d-d6b0-4583-81c4-77627074c9e0" xlink:to="loc_xfor_TemporaryEquityRepurchaseOfConvertiblePreferredStock_f7964b65-9681-4fc9-b665-a4dc731615bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d5cc2994-188a-4493-b6c9-2fb603cae679" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_3daebb1d-d6b0-4583-81c4-77627074c9e0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d5cc2994-188a-4493-b6c9-2fb603cae679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSTOCKREDEEMABLECOMMONSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="xfor-20240331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSTOCKREDEEMABLECOMMONSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSTOCKREDEEMABLECOMMONSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_bbc06cce-6a22-4b4a-b195-532dde1ff370" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2c766436-45ef-48ea-a26d-b4203f9d2b49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_bbc06cce-6a22-4b4a-b195-532dde1ff370" xlink:to="loc_us-gaap_StatementTable_2c766436-45ef-48ea-a26d-b4203f9d2b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8af0312e-166f-461e-bd8f-7cd2c7e37ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2c766436-45ef-48ea-a26d-b4203f9d2b49" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8af0312e-166f-461e-bd8f-7cd2c7e37ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b16e6be9-edb3-4f82-a9aa-1514bf975793" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8af0312e-166f-461e-bd8f-7cd2c7e37ce6" xlink:to="loc_us-gaap_EquityComponentDomain_b16e6be9-edb3-4f82-a9aa-1514bf975793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d8e3fbfb-6669-4974-976b-83cfb41a7758" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b16e6be9-edb3-4f82-a9aa-1514bf975793" xlink:to="loc_us-gaap_CommonStockMember_d8e3fbfb-6669-4974-976b-83cfb41a7758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_356c3243-1809-4993-821a-583e3396dd6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b16e6be9-edb3-4f82-a9aa-1514bf975793" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_356c3243-1809-4993-821a-583e3396dd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a202e7a1-5a56-4cb1-96c5-4f207861a664" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b16e6be9-edb3-4f82-a9aa-1514bf975793" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a202e7a1-5a56-4cb1-96c5-4f207861a664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8402fa0c-1bc4-4aee-8653-fb7b4fd72ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b16e6be9-edb3-4f82-a9aa-1514bf975793" xlink:to="loc_us-gaap_RetainedEarningsMember_8402fa0c-1bc4-4aee-8653-fb7b4fd72ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_590981f8-94a5-465e-9372-c238a8e1573f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2c766436-45ef-48ea-a26d-b4203f9d2b49" xlink:to="loc_us-gaap_StatementLineItems_590981f8-94a5-465e-9372-c238a8e1573f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8cf7b08d-1056-4eab-9010-5ea19491edc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_590981f8-94a5-465e-9372-c238a8e1573f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8cf7b08d-1056-4eab-9010-5ea19491edc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_00f468b9-9eb1-4e44-a750-101fd598485e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8cf7b08d-1056-4eab-9010-5ea19491edc5" xlink:to="loc_us-gaap_SharesOutstanding_00f468b9-9eb1-4e44-a750-101fd598485e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6ba17d8f-981b-42a0-8cf3-507695c79c48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8cf7b08d-1056-4eab-9010-5ea19491edc5" xlink:to="loc_us-gaap_StockholdersEquity_6ba17d8f-981b-42a0-8cf3-507695c79c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_8314b5a5-3a9f-4ea8-8ebe-b378be879a61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8cf7b08d-1056-4eab-9010-5ea19491edc5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_8314b5a5-3a9f-4ea8-8ebe-b378be879a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_e9a5894b-1d0d-4489-a981-45c81749369c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8cf7b08d-1056-4eab-9010-5ea19491edc5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_e9a5894b-1d0d-4489-a981-45c81749369c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_a104bc15-7819-42a4-b189-b02bd6715095" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8cf7b08d-1056-4eab-9010-5ea19491edc5" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_a104bc15-7819-42a4-b189-b02bd6715095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_df86d755-8e2e-4a23-8ca2-56294760e026" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8cf7b08d-1056-4eab-9010-5ea19491edc5" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_df86d755-8e2e-4a23-8ca2-56294760e026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2a1afad9-dbcc-4cf6-9784-fa1ddbb97727" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8cf7b08d-1056-4eab-9010-5ea19491edc5" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2a1afad9-dbcc-4cf6-9784-fa1ddbb97727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_3f8f91e6-d030-4186-9e41-b5d601e0d8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8cf7b08d-1056-4eab-9010-5ea19491edc5" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_3f8f91e6-d030-4186-9e41-b5d601e0d8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bef4c9b6-d398-429d-a876-84683a84ed7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8cf7b08d-1056-4eab-9010-5ea19491edc5" xlink:to="loc_us-gaap_NetIncomeLoss_bef4c9b6-d398-429d-a876-84683a84ed7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_c50e50df-d9a6-4b2f-9bfa-d4e2889fc880" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8cf7b08d-1056-4eab-9010-5ea19491edc5" xlink:to="loc_us-gaap_SharesOutstanding_c50e50df-d9a6-4b2f-9bfa-d4e2889fc880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_573ec096-87ca-4b24-a4cb-c1e0d3a0bfa5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8cf7b08d-1056-4eab-9010-5ea19491edc5" xlink:to="loc_us-gaap_StockholdersEquity_573ec096-87ca-4b24-a4cb-c1e0d3a0bfa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="xfor-20240331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_03ff28d0-4bcb-4fe1-8c3b-acd25f4bf388" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e4bdcb14-2eee-4f9f-9324-9bc3db8b8af8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_03ff28d0-4bcb-4fe1-8c3b-acd25f4bf388" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e4bdcb14-2eee-4f9f-9324-9bc3db8b8af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_837bb227-7888-4c82-b881-1fb5109237a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e4bdcb14-2eee-4f9f-9324-9bc3db8b8af8" xlink:to="loc_us-gaap_NetIncomeLoss_837bb227-7888-4c82-b881-1fb5109237a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b58a4171-c24c-4cc0-b256-8b875479787d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e4bdcb14-2eee-4f9f-9324-9bc3db8b8af8" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b58a4171-c24c-4cc0-b256-8b875479787d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ffec910d-fcd2-4cb6-ab9a-2e5f3f43dab2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b58a4171-c24c-4cc0-b256-8b875479787d" xlink:to="loc_us-gaap_ShareBasedCompensation_ffec910d-fcd2-4cb6-ab9a-2e5f3f43dab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a36bfb18-e373-4ae5-a626-4c8b24beaf4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b58a4171-c24c-4cc0-b256-8b875479787d" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a36bfb18-e373-4ae5-a626-4c8b24beaf4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_NonCashLeaseExpense_662342d7-9169-4540-9a5d-53d6ba20c9b2" xlink:href="xfor-20240331.xsd#xfor_NonCashLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b58a4171-c24c-4cc0-b256-8b875479787d" xlink:to="loc_xfor_NonCashLeaseExpense_662342d7-9169-4540-9a5d-53d6ba20c9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_NonCashInterestExpense_8bbad731-ba5a-4c07-8288-876aa2c96d06" xlink:href="xfor-20240331.xsd#xfor_NonCashInterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b58a4171-c24c-4cc0-b256-8b875479787d" xlink:to="loc_xfor_NonCashInterestExpense_8bbad731-ba5a-4c07-8288-876aa2c96d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_c12eda75-2f72-4a69-9521-b948c326b11c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b58a4171-c24c-4cc0-b256-8b875479787d" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_c12eda75-2f72-4a69-9521-b948c326b11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_85a07077-9b18-4b63-b353-6b4e5265cc00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b58a4171-c24c-4cc0-b256-8b875479787d" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_85a07077-9b18-4b63-b353-6b4e5265cc00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1e5201c2-effb-407e-865e-c9e87c1055bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b58a4171-c24c-4cc0-b256-8b875479787d" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1e5201c2-effb-407e-865e-c9e87c1055bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cf7bdd23-bf33-4d36-af7f-678d12a8ccf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1e5201c2-effb-407e-865e-c9e87c1055bc" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cf7bdd23-bf33-4d36-af7f-678d12a8ccf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8e236fb5-20fe-4736-96ce-afddb70b5565" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1e5201c2-effb-407e-865e-c9e87c1055bc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8e236fb5-20fe-4736-96ce-afddb70b5565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9fa8f5cb-b57b-45fd-9272-a6cb03a09a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1e5201c2-effb-407e-865e-c9e87c1055bc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9fa8f5cb-b57b-45fd-9272-a6cb03a09a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IncreaseDecreaseInLeaseLiabilities_e3f0f3d4-796a-419a-948c-ea1a3f0aa9f1" xlink:href="xfor-20240331.xsd#xfor_IncreaseDecreaseInLeaseLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1e5201c2-effb-407e-865e-c9e87c1055bc" xlink:to="loc_xfor_IncreaseDecreaseInLeaseLiabilities_e3f0f3d4-796a-419a-948c-ea1a3f0aa9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_11578787-aa71-47dd-b271-5ee4835db4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e4bdcb14-2eee-4f9f-9324-9bc3db8b8af8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_11578787-aa71-47dd-b271-5ee4835db4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_06092d21-fc7a-40c6-bdc2-b7a5bdd0a438" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_03ff28d0-4bcb-4fe1-8c3b-acd25f4bf388" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_06092d21-fc7a-40c6-bdc2-b7a5bdd0a438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_8792c158-dead-4cd8-beba-1a2c632bc605" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_06092d21-fc7a-40c6-bdc2-b7a5bdd0a438" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_8792c158-dead-4cd8-beba-1a2c632bc605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_67b14c1a-380f-4900-89ed-23df8fc0286f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_06092d21-fc7a-40c6-bdc2-b7a5bdd0a438" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_67b14c1a-380f-4900-89ed-23df8fc0286f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_fe6686f5-8559-4f29-9675-051718ae4946" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_06092d21-fc7a-40c6-bdc2-b7a5bdd0a438" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_fe6686f5-8559-4f29-9675-051718ae4946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_99498f4e-7673-448d-8144-1f4ac547ef08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_06092d21-fc7a-40c6-bdc2-b7a5bdd0a438" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_99498f4e-7673-448d-8144-1f4ac547ef08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b1b0cae6-df8d-4f3c-b14e-fcdc5078794a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_03ff28d0-4bcb-4fe1-8c3b-acd25f4bf388" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b1b0cae6-df8d-4f3c-b14e-fcdc5078794a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceCostsRelatedToSaleOfWarrantsAndFeesPaidForAmendmentsToLoanAndSecurityAgreement_3d43026e-8d70-44a9-b855-dc8c528ee98e" xlink:href="xfor-20240331.xsd#xfor_IssuanceCostsRelatedToSaleOfWarrantsAndFeesPaidForAmendmentsToLoanAndSecurityAgreement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b1b0cae6-df8d-4f3c-b14e-fcdc5078794a" xlink:to="loc_xfor_IssuanceCostsRelatedToSaleOfWarrantsAndFeesPaidForAmendmentsToLoanAndSecurityAgreement_3d43026e-8d70-44a9-b855-dc8c528ee98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_c4819af6-a671-41ea-8641-f35249676654" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b1b0cae6-df8d-4f3c-b14e-fcdc5078794a" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_c4819af6-a671-41ea-8641-f35249676654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts_d43a934c-d55c-48cf-8532-73cc48892e88" xlink:href="xfor-20240331.xsd#xfor_ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b1b0cae6-df8d-4f3c-b14e-fcdc5078794a" xlink:to="loc_xfor_ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts_d43a934c-d55c-48cf-8532-73cc48892e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_047be31a-b624-4cbd-a047-6aee645e4247" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b1b0cae6-df8d-4f3c-b14e-fcdc5078794a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_047be31a-b624-4cbd-a047-6aee645e4247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_133a39e4-a1c7-4699-8638-6ae1790fa104" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_03ff28d0-4bcb-4fe1-8c3b-acd25f4bf388" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_133a39e4-a1c7-4699-8638-6ae1790fa104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_18cb4dae-9999-41d3-91be-e74f1bd90ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_03ff28d0-4bcb-4fe1-8c3b-acd25f4bf388" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_18cb4dae-9999-41d3-91be-e74f1bd90ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_99fa8c26-53b9-40ef-8838-2ead140f67c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_03ff28d0-4bcb-4fe1-8c3b-acd25f4bf388" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_99fa8c26-53b9-40ef-8838-2ead140f67c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cd9e74cb-8dc9-4706-8c86-2346bc7283d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_03ff28d0-4bcb-4fe1-8c3b-acd25f4bf388" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cd9e74cb-8dc9-4706-8c86-2346bc7283d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/NatureoftheBusinessandBasisofPresentation" xlink:type="simple" xlink:href="xfor-20240331.xsd#NatureoftheBusinessandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/NatureoftheBusinessandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_43afc91e-5097-4417-a2d4-4f188297a8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_76daf7ce-502f-4579-a32d-c6ae01297fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_43afc91e-5097-4417-a2d4-4f188297a8f6" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_76daf7ce-502f-4579-a32d-c6ae01297fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="xfor-20240331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_23e6329a-d6a2-4f34-91d2-eed13e756f72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_fa932da6-02b9-4b74-b6f2-6b51f2047911" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_23e6329a-d6a2-4f34-91d2-eed13e756f72" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_fa932da6-02b9-4b74-b6f2-6b51f2047911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreements" xlink:type="simple" xlink:href="xfor-20240331.xsd#LicenseCollaborationandFundingAgreements"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b900f280-6394-46b4-8826-cd874b491b13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_d9a82df5-0b75-4aeb-b0cb-364d823b4655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b900f280-6394-46b4-8826-cd874b491b13" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_d9a82df5-0b75-4aeb-b0cb-364d823b4655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilities" xlink:type="simple" xlink:href="xfor-20240331.xsd#FairValueofFinancialAssetsandLiabilities"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_15541cf0-fe87-4d0c-82f8-5ec36e8fe2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_8849e4ad-8e21-475c-9128-e7e7312dffac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_15541cf0-fe87-4d0c-82f8-5ec36e8fe2ed" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_8849e4ad-8e21-475c-9128-e7e7312dffac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/PropertyandEquipmentNet" xlink:type="simple" xlink:href="xfor-20240331.xsd#PropertyandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/PropertyandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a265f3b9-3c90-4e52-afd5-ecd8211ed10e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_85b26c2a-d7eb-45c6-8459-59473e98de5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a265f3b9-3c90-4e52-afd5-ecd8211ed10e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_85b26c2a-d7eb-45c6-8459-59473e98de5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/AccruedExpenses" xlink:type="simple" xlink:href="xfor-20240331.xsd#AccruedExpenses"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/AccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_0ae87998-ffa8-4ed1-b31e-3472a66ba395" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AccruedExpensesTextBlock_1e0594e4-a39a-4c1a-a4b2-0e0882655f84" xlink:href="xfor-20240331.xsd#xfor_AccruedExpensesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0ae87998-ffa8-4ed1-b31e-3472a66ba395" xlink:to="loc_xfor_AccruedExpensesTextBlock_1e0594e4-a39a-4c1a-a4b2-0e0882655f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LongTermDebt" xlink:type="simple" xlink:href="xfor-20240331.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_455996c9-7476-47cc-ba81-f7220e7189a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_71d0534f-0222-4511-9dee-bd9a966959e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_455996c9-7476-47cc-ba81-f7220e7189a5" xlink:to="loc_us-gaap_LongTermDebtTextBlock_71d0534f-0222-4511-9dee-bd9a966959e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/Leases" xlink:type="simple" xlink:href="xfor-20240331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_975ace17-689b-442f-9ad4-4f7d2eb357ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_5b2c1c90-2100-45de-acf2-6bec0eed0386" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_975ace17-689b-442f-9ad4-4f7d2eb357ce" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_5b2c1c90-2100-45de-acf2-6bec0eed0386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/CommitmentandContingencies" xlink:type="simple" xlink:href="xfor-20240331.xsd#CommitmentandContingencies"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CommitmentandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_817c8d69-1883-4e9c-a0cb-82b29482fbd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4e21caf0-b8bf-4716-b3ef-f9ffb56d842b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_817c8d69-1883-4e9c-a0cb-82b29482fbd2" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4e21caf0-b8bf-4716-b3ef-f9ffb56d842b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/CommonStockWarrants" xlink:type="simple" xlink:href="xfor-20240331.xsd#CommonStockWarrants"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CommonStockWarrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9472ca2e-a786-4bd8-a9af-5071cf46bc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_d31e042a-4760-44a3-922e-d06dac795239" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9472ca2e-a786-4bd8-a9af-5071cf46bc7c" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_d31e042a-4760-44a3-922e-d06dac795239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="xfor-20240331.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_80123389-bba5-40a1-abda-7295bcf63694" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_aa4d3c17-0142-40ee-90ab-bf5a58606343" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_80123389-bba5-40a1-abda-7295bcf63694" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_aa4d3c17-0142-40ee-90ab-bf5a58606343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="xfor-20240331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c4573eb4-11cd-48a6-8d25-92e6cf3d27f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f77fb78d-2f24-4e46-b1d1-78f1882273b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c4573eb4-11cd-48a6-8d25-92e6cf3d27f8" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f77fb78d-2f24-4e46-b1d1-78f1882273b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/NetLossperShare" xlink:type="simple" xlink:href="xfor-20240331.xsd#NetLossperShare"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/NetLossperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b375430f-c154-4a42-8349-dae403189a96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_88d5370d-3dc2-4020-be7b-b55dc7ad1d55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b375430f-c154-4a42-8349-dae403189a96" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_88d5370d-3dc2-4020-be7b-b55dc7ad1d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="xfor-20240331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3a31e6e4-9f93-43e0-a71f-0cab6a6647d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_8335a967-6454-4db6-ba10-f766c48c533d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a31e6e4-9f93-43e0-a71f-0cab6a6647d2" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_8335a967-6454-4db6-ba10-f766c48c533d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_583416d3-be25-4f2d-9b05-c0648ba0c47d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a31e6e4-9f93-43e0-a71f-0cab6a6647d2" xlink:to="loc_us-gaap_UseOfEstimates_583416d3-be25-4f2d-9b05-c0648ba0c47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_3ac5aff3-2be0-41a4-8940-0dbfeb3a4541" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a31e6e4-9f93-43e0-a71f-0cab6a6647d2" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_3ac5aff3-2be0-41a4-8940-0dbfeb3a4541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9cb50a1f-2638-4fbc-b4ad-54047c6f7d50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a31e6e4-9f93-43e0-a71f-0cab6a6647d2" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9cb50a1f-2638-4fbc-b4ad-54047c6f7d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_b212924f-6f9b-4a2d-847b-a088505b4075" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a31e6e4-9f93-43e0-a71f-0cab6a6647d2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_b212924f-6f9b-4a2d-847b-a088505b4075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="xfor-20240331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0b4879ef-4686-4937-b67c-870bcb017cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensatingBalancesTextBlock_dc99b500-a283-4dd6-a3e8-4b52ebdc42ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCompensatingBalancesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b4879ef-4686-4937-b67c-870bcb017cd0" xlink:to="loc_us-gaap_ScheduleOfCompensatingBalancesTextBlock_dc99b500-a283-4dd6-a3e8-4b52ebdc42ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToCashFlowsTableTextBlock_805f6261-a290-40e5-b4ef-7a8cb88be44a" xlink:href="xfor-20240331.xsd#xfor_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToCashFlowsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b4879ef-4686-4937-b67c-870bcb017cd0" xlink:to="loc_xfor_ScheduleOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashToCashFlowsTableTextBlock_805f6261-a290-40e5-b4ef-7a8cb88be44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesTables" xlink:type="simple" xlink:href="xfor-20240331.xsd#FairValueofFinancialAssetsandLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_89cacecd-b9d1-4b85-bb40-d684c203aaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_3a8076ee-922e-448a-85a3-422f2ce2ccc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_89cacecd-b9d1-4b85-bb40-d684c203aaf3" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_3a8076ee-922e-448a-85a3-422f2ce2ccc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_a99601d1-6f40-45fb-8991-17e0401e1246" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_89cacecd-b9d1-4b85-bb40-d684c203aaf3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_a99601d1-6f40-45fb-8991-17e0401e1246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_29c79878-2a5c-4343-b6af-d6e0552cb498" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_89cacecd-b9d1-4b85-bb40-d684c203aaf3" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_29c79878-2a5c-4343-b6af-d6e0552cb498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a996685d-e749-44c8-aa29-02b419dac15e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_89cacecd-b9d1-4b85-bb40-d684c203aaf3" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a996685d-e749-44c8-aa29-02b419dac15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/PropertyandEquipmentNetTables" xlink:type="simple" xlink:href="xfor-20240331.xsd#PropertyandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/PropertyandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b013e889-a290-4412-9524-cb01b0c8133f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_e5c46875-341c-4bbd-9478-8958d429e886" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b013e889-a290-4412-9524-cb01b0c8133f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_e5c46875-341c-4bbd-9478-8958d429e886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="xfor-20240331.xsd#AccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/AccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_6a2c23bf-b1d7-417c-a381-59a6de4948f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_0c3288f9-c87b-429c-893f-4ebf7db47638" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_6a2c23bf-b1d7-417c-a381-59a6de4948f2" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_0c3288f9-c87b-429c-893f-4ebf7db47638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="xfor-20240331.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a1357e57-d6d4-4ada-9400-de53fcff5437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_c3b89564-5306-4100-a1de-46d4b1f2affe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a1357e57-d6d4-4ada-9400-de53fcff5437" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_c3b89564-5306-4100-a1de-46d4b1f2affe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_233ec793-d728-4987-b549-f27f86978764" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a1357e57-d6d4-4ada-9400-de53fcff5437" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_233ec793-d728-4987-b549-f27f86978764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_27c59017-4086-4fd5-a41a-7949913e6a58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a1357e57-d6d4-4ada-9400-de53fcff5437" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_27c59017-4086-4fd5-a41a-7949913e6a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LeasesTables" xlink:type="simple" xlink:href="xfor-20240331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8b5b4b21-fa68-49f7-b51f-6494c783c352" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_273a5745-86cc-4413-84ed-184652f1dd97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8b5b4b21-fa68-49f7-b51f-6494c783c352" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_273a5745-86cc-4413-84ed-184652f1dd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_989598aa-3969-4edd-873a-daa5e2d9aef6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8b5b4b21-fa68-49f7-b51f-6494c783c352" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_989598aa-3969-4edd-873a-daa5e2d9aef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/CommonStockWarrantsTables" xlink:type="simple" xlink:href="xfor-20240331.xsd#CommonStockWarrantsTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CommonStockWarrantsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f96b75e2-0bf8-41b4-9e0e-a0b6b4dd587b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_5fc7ee70-b3af-43d1-93b3-67bfc2d753e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f96b75e2-0bf8-41b4-9e0e-a0b6b4dd587b" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_5fc7ee70-b3af-43d1-93b3-67bfc2d753e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="xfor-20240331.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b900a89e-c6fe-46ec-98fe-806dfe2e0f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_13fea5d7-37f9-4252-bea9-a24d81ab9790" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b900a89e-c6fe-46ec-98fe-806dfe2e0f6f" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_13fea5d7-37f9-4252-bea9-a24d81ab9790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ca1f0cc2-5024-4045-9cbf-7f5ca5558ded" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b900a89e-c6fe-46ec-98fe-806dfe2e0f6f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ca1f0cc2-5024-4045-9cbf-7f5ca5558ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_722a527b-e9e7-46d8-8071-c057b057ab7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b900a89e-c6fe-46ec-98fe-806dfe2e0f6f" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_722a527b-e9e7-46d8-8071-c057b057ab7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_f94efbdf-376e-4fe8-a8ca-c34d89a68fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b900a89e-c6fe-46ec-98fe-806dfe2e0f6f" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_f94efbdf-376e-4fe8-a8ca-c34d89a68fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_b545d5d2-58ee-48ee-91ab-4c376226494b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b900a89e-c6fe-46ec-98fe-806dfe2e0f6f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_b545d5d2-58ee-48ee-91ab-4c376226494b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/NetLossperShareTables" xlink:type="simple" xlink:href="xfor-20240331.xsd#NetLossperShareTables"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/NetLossperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d559a897-caa4-4e93-8d7a-b760e4043d12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_897f8fee-6ae5-4ca9-8362-29f256d3991a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d559a897-caa4-4e93-8d7a-b760e4043d12" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_897f8fee-6ae5-4ca9-8362-29f256d3991a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1f1a4507-1d68-4014-8f46-d9a9fde083ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d559a897-caa4-4e93-8d7a-b760e4043d12" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1f1a4507-1d68-4014-8f46-d9a9fde083ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/NatureoftheBusinessandBasisofPresentationAdditionalInformationDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#NatureoftheBusinessandBasisofPresentationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/NatureoftheBusinessandBasisofPresentationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_da666f94-f86b-4a3c-b2c6-427ae55386c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ScheduleOfAccountingPoliciesTable_7a0bec37-56d2-44c3-b76e-0747a6661102" xlink:href="xfor-20240331.xsd#xfor_ScheduleOfAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_da666f94-f86b-4a3c-b2c6-427ae55386c4" xlink:to="loc_xfor_ScheduleOfAccountingPoliciesTable_7a0bec37-56d2-44c3-b76e-0747a6661102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2f90d3fc-2048-4a0a-91ae-2267e10dfeff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_ScheduleOfAccountingPoliciesTable_7a0bec37-56d2-44c3-b76e-0747a6661102" xlink:to="loc_us-gaap_CreditFacilityAxis_2f90d3fc-2048-4a0a-91ae-2267e10dfeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f229fd96-fcc4-4f0e-a7e7-e3299eafff3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_2f90d3fc-2048-4a0a-91ae-2267e10dfeff" xlink:to="loc_us-gaap_CreditFacilityDomain_f229fd96-fcc4-4f0e-a7e7-e3299eafff3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_MinCashTestDate1Member_38e78ec3-ff2c-4de3-8a5b-4eea00b87f04" xlink:href="xfor-20240331.xsd#xfor_MinCashTestDate1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f229fd96-fcc4-4f0e-a7e7-e3299eafff3c" xlink:to="loc_xfor_MinCashTestDate1Member_38e78ec3-ff2c-4de3-8a5b-4eea00b87f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3a306254-2575-45fe-9af9-05c312faa812" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_ScheduleOfAccountingPoliciesTable_7a0bec37-56d2-44c3-b76e-0747a6661102" xlink:to="loc_us-gaap_DebtInstrumentAxis_3a306254-2575-45fe-9af9-05c312faa812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a660840e-e05e-42c1-87e1-1423cc16ceb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3a306254-2575-45fe-9af9-05c312faa812" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a660840e-e05e-42c1-87e1-1423cc16ceb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_HerculesSecondAmendedLoanAgreementMember_e1159542-4992-40c1-aa6e-8adfad8f5c39" xlink:href="xfor-20240331.xsd#xfor_HerculesSecondAmendedLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a660840e-e05e-42c1-87e1-1423cc16ceb4" xlink:to="loc_xfor_HerculesSecondAmendedLoanAgreementMember_e1159542-4992-40c1-aa6e-8adfad8f5c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_cb0ba241-df5c-4ef6-a6c6-312f297cdc2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_ScheduleOfAccountingPoliciesTable_7a0bec37-56d2-44c3-b76e-0747a6661102" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_cb0ba241-df5c-4ef6-a6c6-312f297cdc2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_84826a67-03ea-4b2d-b92d-bf117a0d9106" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb0ba241-df5c-4ef6-a6c6-312f297cdc2d" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_84826a67-03ea-4b2d-b92d-bf117a0d9106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d9f71928-4f9e-445d-a9e4-10bb25713acd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb0ba241-df5c-4ef6-a6c6-312f297cdc2d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d9f71928-4f9e-445d-a9e4-10bb25713acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_904d6abc-f60a-4123-9b30-7b53d9815513" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb0ba241-df5c-4ef6-a6c6-312f297cdc2d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_904d6abc-f60a-4123-9b30-7b53d9815513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LineOfCreditCovenantMinimumCash_232b962c-b93f-43a9-94d9-c834185f6d26" xlink:href="xfor-20240331.xsd#xfor_LineOfCreditCovenantMinimumCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_cb0ba241-df5c-4ef6-a6c6-312f297cdc2d" xlink:to="loc_xfor_LineOfCreditCovenantMinimumCash_232b962c-b93f-43a9-94d9-c834185f6d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompensatingBalanceArrangementsDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#SummaryofSignificantAccountingPoliciesScheduleofCompensatingBalanceArrangementsDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompensatingBalanceArrangementsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d3f5bc8d-3444-4161-9626-e28d57b1c3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_0accffde-fbd1-4b12-87c5-a56cc548b19d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d3f5bc8d-3444-4161-9626-e28d57b1c3fe" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_0accffde-fbd1-4b12-87c5-a56cc548b19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e6a7c540-00e1-498d-8256-1c860f09abe7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_0accffde-fbd1-4b12-87c5-a56cc548b19d" xlink:to="loc_us-gaap_CreditFacilityAxis_e6a7c540-00e1-498d-8256-1c860f09abe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9c8029c0-9fae-48d5-b0bf-50c54ad56233" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_e6a7c540-00e1-498d-8256-1c860f09abe7" xlink:to="loc_us-gaap_CreditFacilityDomain_9c8029c0-9fae-48d5-b0bf-50c54ad56233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_d4cb6c87-f5dc-41c0-9fe3-0bf2ea627f42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9c8029c0-9fae-48d5-b0bf-50c54ad56233" xlink:to="loc_us-gaap_LetterOfCreditMember_d4cb6c87-f5dc-41c0-9fe3-0bf2ea627f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_6aad5dd2-0b68-4d85-a1f7-61d0e4a92752" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_0accffde-fbd1-4b12-87c5-a56cc548b19d" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_6aad5dd2-0b68-4d85-a1f7-61d0e4a92752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_08f07ca3-64a6-4c8a-ae1b-986dace43b42" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_6aad5dd2-0b68-4d85-a1f7-61d0e4a92752" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_08f07ca3-64a6-4c8a-ae1b-986dace43b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_WalthamLeaseMember_34367cc3-e3c7-45b5-9a07-08061d25e405" xlink:href="xfor-20240331.xsd#xfor_WalthamLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_08f07ca3-64a6-4c8a-ae1b-986dace43b42" xlink:to="loc_xfor_WalthamLeaseMember_34367cc3-e3c7-45b5-9a07-08061d25e405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ViennaLeaseAgreementMember_56bdc90d-9228-4a4d-ac73-c9e1344d89ff" xlink:href="xfor-20240331.xsd#xfor_ViennaLeaseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_08f07ca3-64a6-4c8a-ae1b-986dace43b42" xlink:to="loc_xfor_ViennaLeaseAgreementMember_56bdc90d-9228-4a4d-ac73-c9e1344d89ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AllstonLeaseAgreementMember_4f014dae-0bf8-4873-a413-6a56223bba7c" xlink:href="xfor-20240331.xsd#xfor_AllstonLeaseAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_08f07ca3-64a6-4c8a-ae1b-986dace43b42" xlink:to="loc_xfor_AllstonLeaseAgreementMember_4f014dae-0bf8-4873-a413-6a56223bba7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_a36912f9-9421-43d7-b0f1-9357dca466d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_0accffde-fbd1-4b12-87c5-a56cc548b19d" xlink:to="loc_us-gaap_CashAndCashEquivalentsLineItems_a36912f9-9421-43d7-b0f1-9357dca466d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_8112ea1d-1525-4fdd-b56b-1f038b5092d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_a36912f9-9421-43d7-b0f1-9357dca466d2" xlink:to="loc_us-gaap_RestrictedCash_8112ea1d-1525-4fdd-b56b-1f038b5092d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_01e6eb54-2cb9-4be6-89fd-69f5d1ac18a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_a36912f9-9421-43d7-b0f1-9357dca466d2" xlink:to="loc_us-gaap_RestrictedCashCurrent_01e6eb54-2cb9-4be6-89fd-69f5d1ac18a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_228bdb36-4d0c-43f0-8c0d-d4eaf90be6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_a36912f9-9421-43d7-b0f1-9357dca466d2" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_228bdb36-4d0c-43f0-8c0d-d4eaf90be6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofReconciliationofCashCashEquivalentsandRestrictedCashDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#SummaryofSignificantAccountingPoliciesScheduleofReconciliationofCashCashEquivalentsandRestrictedCashDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/SummaryofSignificantAccountingPoliciesScheduleofReconciliationofCashCashEquivalentsandRestrictedCashDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_706f0ca7-baa1-4a30-95be-f0c0c3933acb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_53fc22d4-93a1-4420-8486-10c49f83fae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_706f0ca7-baa1-4a30-95be-f0c0c3933acb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_53fc22d4-93a1-4420-8486-10c49f83fae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_31594150-988f-4e9b-90c2-107a34787055" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_706f0ca7-baa1-4a30-95be-f0c0c3933acb" xlink:to="loc_us-gaap_RestrictedCashCurrent_31594150-988f-4e9b-90c2-107a34787055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_92c4016e-8597-498b-a45e-acd62fa53bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_706f0ca7-baa1-4a30-95be-f0c0c3933acb" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_92c4016e-8597-498b-a45e-acd62fa53bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_374ed241-e07b-435d-93e7-bf7ae1ccba5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_706f0ca7-baa1-4a30-95be-f0c0c3933acb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_374ed241-e07b-435d-93e7-bf7ae1ccba5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreementsAdditionalInformationDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#LicenseCollaborationandFundingAgreementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LicenseCollaborationandFundingAgreementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7be596d7-56b9-4977-9cb4-af891de12033" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_CollaborationLicenseAndFundingArrangementsTable_605c0911-fe98-4ff8-b1af-3a21267c66ac" xlink:href="xfor-20240331.xsd#xfor_CollaborationLicenseAndFundingArrangementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7be596d7-56b9-4977-9cb4-af891de12033" xlink:to="loc_xfor_CollaborationLicenseAndFundingArrangementsTable_605c0911-fe98-4ff8-b1af-3a21267c66ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_dcb355fe-3891-4c8b-b50c-a0ac2e69a9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_CollaborationLicenseAndFundingArrangementsTable_605c0911-fe98-4ff8-b1af-3a21267c66ac" xlink:to="loc_us-gaap_TypeOfArrangementAxis_dcb355fe-3891-4c8b-b50c-a0ac2e69a9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ef4b503e-b006-4e74-a6f5-f0988e77eb0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_dcb355fe-3891-4c8b-b50c-a0ac2e69a9d6" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ef4b503e-b006-4e74-a6f5-f0988e77eb0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ResearchAndDevelopmentIncentiveProgramMember_b6b46046-4e88-4311-a74e-c1197783f891" xlink:href="xfor-20240331.xsd#xfor_ResearchAndDevelopmentIncentiveProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ef4b503e-b006-4e74-a6f5-f0988e77eb0c" xlink:to="loc_xfor_ResearchAndDevelopmentIncentiveProgramMember_b6b46046-4e88-4311-a74e-c1197783f891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_GenzymeAgreementMember_8bd91509-6bc2-471d-9ebb-193ca73b178a" xlink:href="xfor-20240331.xsd#xfor_GenzymeAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ef4b503e-b006-4e74-a6f5-f0988e77eb0c" xlink:to="loc_xfor_GenzymeAgreementMember_8bd91509-6bc2-471d-9ebb-193ca73b178a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ccb3d913-8213-4519-a535-510f865d51c9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_CollaborationLicenseAndFundingArrangementsTable_605c0911-fe98-4ff8-b1af-3a21267c66ac" xlink:to="loc_srt_CounterpartyNameAxis_ccb3d913-8213-4519-a535-510f865d51c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cb0d8c23-6b3a-43ac-9740-21724efca513" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ccb3d913-8213-4519-a535-510f865d51c9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cb0d8c23-6b3a-43ac-9740-21724efca513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_A6NetSalesMember_f18237a1-9a84-4295-a5fd-cfc93d64ad4d" xlink:href="xfor-20240331.xsd#xfor_A6NetSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cb0d8c23-6b3a-43ac-9740-21724efca513" xlink:to="loc_xfor_A6NetSalesMember_f18237a1-9a84-4295-a5fd-cfc93d64ad4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_A10NetSalesMember_273f41e5-5fcb-49fd-9c2b-34d42c3f2a53" xlink:href="xfor-20240331.xsd#xfor_A10NetSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cb0d8c23-6b3a-43ac-9740-21724efca513" xlink:to="loc_xfor_A10NetSalesMember_273f41e5-5fcb-49fd-9c2b-34d42c3f2a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_A12NetSalesMember_976584ae-3bc3-457c-99f4-85034eace6a2" xlink:href="xfor-20240331.xsd#xfor_A12NetSalesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cb0d8c23-6b3a-43ac-9740-21724efca513" xlink:to="loc_xfor_A12NetSalesMember_976584ae-3bc3-457c-99f4-85034eace6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b122a3ad-9e9d-461a-9633-29b0fd2427b6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_CollaborationLicenseAndFundingArrangementsTable_605c0911-fe98-4ff8-b1af-3a21267c66ac" xlink:to="loc_srt_RangeAxis_b122a3ad-9e9d-461a-9633-29b0fd2427b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3123ad47-7113-4f83-b25f-14737c439342" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b122a3ad-9e9d-461a-9633-29b0fd2427b6" xlink:to="loc_srt_RangeMember_3123ad47-7113-4f83-b25f-14737c439342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a9e25ae2-8726-4e7b-b6cc-cee0ecbeeabb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3123ad47-7113-4f83-b25f-14737c439342" xlink:to="loc_srt_MinimumMember_a9e25ae2-8726-4e7b-b6cc-cee0ecbeeabb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e4b846c6-4feb-435a-b326-8194c1829f67" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3123ad47-7113-4f83-b25f-14737c439342" xlink:to="loc_srt_MaximumMember_e4b846c6-4feb-435a-b326-8194c1829f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_CollaborationLicenseAndFundingArrangementsLineItems_0fdc2d81-cb4b-4d39-9494-b948927300ae" xlink:href="xfor-20240331.xsd#xfor_CollaborationLicenseAndFundingArrangementsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_CollaborationLicenseAndFundingArrangementsTable_605c0911-fe98-4ff8-b1af-3a21267c66ac" xlink:to="loc_xfor_CollaborationLicenseAndFundingArrangementsLineItems_0fdc2d81-cb4b-4d39-9494-b948927300ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_GrantAndIncentiveReceivables_6fce458d-7ee6-4fee-be0a-c0a83d564ee8" xlink:href="xfor-20240331.xsd#xfor_GrantAndIncentiveReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_CollaborationLicenseAndFundingArrangementsLineItems_0fdc2d81-cb4b-4d39-9494-b948927300ae" xlink:to="loc_xfor_GrantAndIncentiveReceivables_6fce458d-7ee6-4fee-be0a-c0a83d564ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_24263c69-f983-43cb-8c9e-597e72bd892f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_CollaborationLicenseAndFundingArrangementsLineItems_0fdc2d81-cb4b-4d39-9494-b948927300ae" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_24263c69-f983-43cb-8c9e-597e72bd892f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_MilestonePayments_fda63774-8379-4d51-8378-1eb922ea0dd8" xlink:href="xfor-20240331.xsd#xfor_MilestonePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_CollaborationLicenseAndFundingArrangementsLineItems_0fdc2d81-cb4b-4d39-9494-b948927300ae" xlink:to="loc_xfor_MilestonePayments_fda63774-8379-4d51-8378-1eb922ea0dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_e3f801d3-5bbf-4ce5-a22e-1499a0438a86" xlink:href="xfor-20240331.xsd#xfor_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_CollaborationLicenseAndFundingArrangementsLineItems_0fdc2d81-cb4b-4d39-9494-b948927300ae" xlink:to="loc_xfor_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_e3f801d3-5bbf-4ce5-a22e-1499a0438a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_RevenuePerformanceObligationPercentageOfNetSale_d12f4e20-ae32-40e5-8e3e-300ad0b5afbf" xlink:href="xfor-20240331.xsd#xfor_RevenuePerformanceObligationPercentageOfNetSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_CollaborationLicenseAndFundingArrangementsLineItems_0fdc2d81-cb4b-4d39-9494-b948927300ae" xlink:to="loc_xfor_RevenuePerformanceObligationPercentageOfNetSale_d12f4e20-ae32-40e5-8e3e-300ad0b5afbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_e5c2d8a6-5b26-4bf4-a39b-24d8f319b6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_CollaborationLicenseAndFundingArrangementsLineItems_0fdc2d81-cb4b-4d39-9494-b948927300ae" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_e5c2d8a6-5b26-4bf4-a39b-24d8f319b6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesScheduleofAssetsandLiabilitiesMeasuredatFairValueDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#FairValueofFinancialAssetsandLiabilitiesScheduleofAssetsandLiabilitiesMeasuredatFairValueDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesScheduleofAssetsandLiabilitiesMeasuredatFairValueDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_41fd3cbe-bc36-477a-bc5f-f7d1d68210da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_42718d00-008b-4e40-ba39-fdd944aa895d" xlink:href="xfor-20240331.xsd#xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_41fd3cbe-bc36-477a-bc5f-f7d1d68210da" xlink:to="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_42718d00-008b-4e40-ba39-fdd944aa895d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b957085b-8fc6-4276-b2e0-04a121eaaf0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_42718d00-008b-4e40-ba39-fdd944aa895d" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b957085b-8fc6-4276-b2e0-04a121eaaf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8c329814-730f-4fcd-8cc0-986bebaaa7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b957085b-8fc6-4276-b2e0-04a121eaaf0d" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8c329814-730f-4fcd-8cc0-986bebaaa7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_2c448ab2-09dc-4d7e-8775-6b9a52bbc642" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8c329814-730f-4fcd-8cc0-986bebaaa7c4" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_2c448ab2-09dc-4d7e-8775-6b9a52bbc642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8c91d9cf-7fe9-4ef6-a9d9-19d5ae268e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_42718d00-008b-4e40-ba39-fdd944aa895d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8c91d9cf-7fe9-4ef6-a9d9-19d5ae268e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eeb66843-8ff4-4c2c-98b2-6e00bd3d82de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8c91d9cf-7fe9-4ef6-a9d9-19d5ae268e6a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eeb66843-8ff4-4c2c-98b2-6e00bd3d82de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_589d28f0-0558-436e-a1bd-4a31b9a681c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eeb66843-8ff4-4c2c-98b2-6e00bd3d82de" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_589d28f0-0558-436e-a1bd-4a31b9a681c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_647897f5-eb84-4341-b055-a685466a6aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eeb66843-8ff4-4c2c-98b2-6e00bd3d82de" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_647897f5-eb84-4341-b055-a685466a6aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_66bcebee-b671-40f2-91e8-1de275604c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eeb66843-8ff4-4c2c-98b2-6e00bd3d82de" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_66bcebee-b671-40f2-91e8-1de275604c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_07b80902-ffdb-4d41-bce9-5f7977ae1942" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_42718d00-008b-4e40-ba39-fdd944aa895d" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_07b80902-ffdb-4d41-bce9-5f7977ae1942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fc14591f-04d7-4f1a-86fa-42003c75da7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_07b80902-ffdb-4d41-bce9-5f7977ae1942" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fc14591f-04d7-4f1a-86fa-42003c75da7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_d9b70e97-bd11-4c3e-9fb2-67bdeb4fd8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fc14591f-04d7-4f1a-86fa-42003c75da7c" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_d9b70e97-bd11-4c3e-9fb2-67bdeb4fd8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_ed04732b-3417-44c5-8545-991771e395da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fc14591f-04d7-4f1a-86fa-42003c75da7c" xlink:to="loc_us-gaap_WarrantMember_ed04732b-3417-44c5-8545-991771e395da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_36f64099-c8b8-4393-9518-649ace6fc179" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_42718d00-008b-4e40-ba39-fdd944aa895d" xlink:to="loc_us-gaap_InvestmentTypeAxis_36f64099-c8b8-4393-9518-649ace6fc179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_cf50c72d-9913-43ed-983f-3b35e472df94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_36f64099-c8b8-4393-9518-649ace6fc179" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_cf50c72d-9913-43ed-983f-3b35e472df94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_ddfb7ab0-1fc1-425d-8769-3d40b10e011c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_cf50c72d-9913-43ed-983f-3b35e472df94" xlink:to="loc_us-gaap_MoneyMarketFundsMember_ddfb7ab0-1fc1-425d-8769-3d40b10e011c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBillSecuritiesMember_299850ad-8a85-439b-8518-8e313b25f55f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_cf50c72d-9913-43ed-983f-3b35e472df94" xlink:to="loc_us-gaap_USTreasuryBillSecuritiesMember_299850ad-8a85-439b-8518-8e313b25f55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_51e719a7-4e7f-4ca8-b72d-b5aac2e9214a" xlink:href="xfor-20240331.xsd#xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_42718d00-008b-4e40-ba39-fdd944aa895d" xlink:to="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_51e719a7-4e7f-4ca8-b72d-b5aac2e9214a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_ba89b626-6e3f-41d8-9126-b00cf6ae33d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_51e719a7-4e7f-4ca8-b72d-b5aac2e9214a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_ba89b626-6e3f-41d8-9126-b00cf6ae33d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_0a3f9fcb-030b-4d41-9170-57c5cbcc4e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_51e719a7-4e7f-4ca8-b72d-b5aac2e9214a" xlink:to="loc_us-gaap_DerivativeLiabilities_0a3f9fcb-030b-4d41-9170-57c5cbcc4e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesDebtSecuritiesAvailableforSaleDetails" xlink:type="simple" xlink:href="xfor-20240331.xsd#FairValueofFinancialAssetsandLiabilitiesDebtSecuritiesAvailableforSaleDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesDebtSecuritiesAvailableforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_48bcd9e7-ed3d-454d-b3bf-a266be1fadfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c401def2-0096-4e92-8096-16559ca5482c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_48bcd9e7-ed3d-454d-b3bf-a266be1fadfc" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c401def2-0096-4e92-8096-16559ca5482c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2a0f7769-c5ae-4b1a-969f-d65ac2f7c883" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c401def2-0096-4e92-8096-16559ca5482c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2a0f7769-c5ae-4b1a-969f-d65ac2f7c883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_054a7e5b-b83a-4e69-8391-272f753fee2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2a0f7769-c5ae-4b1a-969f-d65ac2f7c883" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_054a7e5b-b83a-4e69-8391-272f753fee2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_4776d700-3642-4398-94ea-da6ab11b4240" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_054a7e5b-b83a-4e69-8391-272f753fee2e" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_4776d700-3642-4398-94ea-da6ab11b4240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_ca4fb9cd-341c-490e-b1df-0f8135b5667d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_054a7e5b-b83a-4e69-8391-272f753fee2e" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_ca4fb9cd-341c-490e-b1df-0f8135b5667d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8d3cfcf8-ff9b-43cf-81b9-ed79e2e01ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c401def2-0096-4e92-8096-16559ca5482c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8d3cfcf8-ff9b-43cf-81b9-ed79e2e01ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e488bb95-5f94-4798-a8fe-e258335132ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8d3cfcf8-ff9b-43cf-81b9-ed79e2e01ffb" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e488bb95-5f94-4798-a8fe-e258335132ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2295e8ce-ba3a-44fd-9d71-9099d7da0cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8d3cfcf8-ff9b-43cf-81b9-ed79e2e01ffb" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2295e8ce-ba3a-44fd-9d71-9099d7da0cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_53c96597-1e2c-45f3-b658-7cb2f34d0dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8d3cfcf8-ff9b-43cf-81b9-ed79e2e01ffb" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_53c96597-1e2c-45f3-b658-7cb2f34d0dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dabb559e-e0f9-4c6d-92e1-54c45de7634c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8d3cfcf8-ff9b-43cf-81b9-ed79e2e01ffb" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dabb559e-e0f9-4c6d-92e1-54c45de7634c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesAggregateFairValuesFinancialInstrumentsDetails" xlink:type="simple" xlink:href="xfor-20240331.xsd#FairValueofFinancialAssetsandLiabilitiesAggregateFairValuesFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesAggregateFairValuesFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4006d148-aabf-4f5b-bb76-129fb3d7b823" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_b7bf5867-89dc-4b07-8ac8-5a1162f22019" xlink:href="xfor-20240331.xsd#xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4006d148-aabf-4f5b-bb76-129fb3d7b823" xlink:to="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_b7bf5867-89dc-4b07-8ac8-5a1162f22019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_92b98794-fd9a-4afd-8b57-6df26e49dbab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_b7bf5867-89dc-4b07-8ac8-5a1162f22019" xlink:to="loc_us-gaap_FinancialInstrumentAxis_92b98794-fd9a-4afd-8b57-6df26e49dbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1cd21ef8-2ec3-490f-808e-cb3dbe0e6079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_92b98794-fd9a-4afd-8b57-6df26e49dbab" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1cd21ef8-2ec3-490f-808e-cb3dbe0e6079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_25bbb6bc-2577-4ee9-91b6-c34f7c5922bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1cd21ef8-2ec3-490f-808e-cb3dbe0e6079" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_25bbb6bc-2577-4ee9-91b6-c34f7c5922bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_55593b44-3c70-4fe4-9c7d-65b7c2f04d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1cd21ef8-2ec3-490f-808e-cb3dbe0e6079" xlink:to="loc_us-gaap_WarrantMember_55593b44-3c70-4fe4-9c7d-65b7c2f04d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_87a13548-0706-4ad5-8a08-3f7cc0e80f62" xlink:href="xfor-20240331.xsd#xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_b7bf5867-89dc-4b07-8ac8-5a1162f22019" xlink:to="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_87a13548-0706-4ad5-8a08-3f7cc0e80f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9a69ef2a-4ab0-4a9c-8c0b-160b0709f37e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_87a13548-0706-4ad5-8a08-3f7cc0e80f62" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9a69ef2a-4ab0-4a9c-8c0b-160b0709f37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_87013024-f493-4f3b-99d9-150886357094" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9a69ef2a-4ab0-4a9c-8c0b-160b0709f37e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_87013024-f493-4f3b-99d9-150886357094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d572eb42-54fd-40ec-8b5d-5a1d26abbfc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9a69ef2a-4ab0-4a9c-8c0b-160b0709f37e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d572eb42-54fd-40ec-8b5d-5a1d26abbfc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1efb6530-1d46-41c9-9b9d-6b6a1a6a7419" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9a69ef2a-4ab0-4a9c-8c0b-160b0709f37e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1efb6530-1d46-41c9-9b9d-6b6a1a6a7419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="xfor-20240331.xsd#FairValueofFinancialAssetsandLiabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ce6a861d-dc53-4195-9d48-91c95e167546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_e0b54bcf-7015-4ecd-818a-aeef0da85b4b" xlink:href="xfor-20240331.xsd#xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ce6a861d-dc53-4195-9d48-91c95e167546" xlink:to="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_e0b54bcf-7015-4ecd-818a-aeef0da85b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_9a7096fa-89f9-4d39-89df-e58322fe5a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_e0b54bcf-7015-4ecd-818a-aeef0da85b4b" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_9a7096fa-89f9-4d39-89df-e58322fe5a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_87c1578b-8e01-4887-a5ba-d98cd1b7b441" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_9a7096fa-89f9-4d39-89df-e58322fe5a0b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_87c1578b-8e01-4887-a5ba-d98cd1b7b441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_628f3a7b-795d-4171-9da6-0f409fcdcafa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_87c1578b-8e01-4887-a5ba-d98cd1b7b441" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_628f3a7b-795d-4171-9da6-0f409fcdcafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_389e7108-e7ba-4319-8b86-640fa377daea" xlink:href="xfor-20240331.xsd#xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_e0b54bcf-7015-4ecd-818a-aeef0da85b4b" xlink:to="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_389e7108-e7ba-4319-8b86-640fa377daea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_111ccce9-5f9b-44fb-9dc9-1144c6be4e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_389e7108-e7ba-4319-8b86-640fa377daea" xlink:to="loc_us-gaap_DerivativeLiabilities_111ccce9-5f9b-44fb-9dc9-1144c6be4e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesFairValueAssumptionsDetails" xlink:type="simple" xlink:href="xfor-20240331.xsd#FairValueofFinancialAssetsandLiabilitiesFairValueAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/FairValueofFinancialAssetsandLiabilitiesFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_702c9523-4a64-4e5d-a981-3ed0a25e59fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ade55f1d-434a-4835-8603-2b2ba9401dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_702c9523-4a64-4e5d-a981-3ed0a25e59fc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ade55f1d-434a-4835-8603-2b2ba9401dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9974c17f-5490-42a4-9c72-c30161ccc201" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ade55f1d-434a-4835-8603-2b2ba9401dfa" xlink:to="loc_us-gaap_AwardTypeAxis_9974c17f-5490-42a4-9c72-c30161ccc201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_88414270-fd03-4581-8fff-e66c215a0a06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9974c17f-5490-42a4-9c72-c30161ccc201" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_88414270-fd03-4581-8fff-e66c215a0a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_e1baeacf-c583-492a-b5f5-5254b6f0179b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_88414270-fd03-4581-8fff-e66c215a0a06" xlink:to="loc_us-gaap_WarrantMember_e1baeacf-c583-492a-b5f5-5254b6f0179b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80ac52cc-e1a2-4d0f-8c50-59d13b60cac1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ade55f1d-434a-4835-8603-2b2ba9401dfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80ac52cc-e1a2-4d0f-8c50-59d13b60cac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_0cae90b0-7533-48e0-ba79-b5d3c89e9626" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80ac52cc-e1a2-4d0f-8c50-59d13b60cac1" xlink:to="loc_us-gaap_SharePrice_0cae90b0-7533-48e0-ba79-b5d3c89e9626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a3e486ff-18e9-412a-9f67-352f12eecf53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80ac52cc-e1a2-4d0f-8c50-59d13b60cac1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a3e486ff-18e9-412a-9f67-352f12eecf53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6f5ae687-382f-415f-b076-8644e437da45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80ac52cc-e1a2-4d0f-8c50-59d13b60cac1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6f5ae687-382f-415f-b076-8644e437da45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_237b6438-622e-4638-a30c-4521de15602a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80ac52cc-e1a2-4d0f-8c50-59d13b60cac1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_237b6438-622e-4638-a30c-4521de15602a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_591203d3-fe46-4025-8f0a-ea8ee86a75f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80ac52cc-e1a2-4d0f-8c50-59d13b60cac1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_591203d3-fe46-4025-8f0a-ea8ee86a75f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6c10ce0d-578a-4437-923b-6b613de82593" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80ac52cc-e1a2-4d0f-8c50-59d13b60cac1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6c10ce0d-578a-4437-923b-6b613de82593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentNetDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#PropertyandEquipmentNetScheduleofPropertyandEquipmentNetDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentNetDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_28714e5c-887f-4ad0-b0e5-33127fa0a659" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b4a7d96e-bc0f-4b42-a2c5-41cf3ef3a6a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_28714e5c-887f-4ad0-b0e5-33127fa0a659" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b4a7d96e-bc0f-4b42-a2c5-41cf3ef3a6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_25a2b741-f5a4-4fce-9884-c820424888e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b4a7d96e-bc0f-4b42-a2c5-41cf3ef3a6a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_25a2b741-f5a4-4fce-9884-c820424888e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f3b7c3f-735e-46a2-a488-e5c3802e4633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_25a2b741-f5a4-4fce-9884-c820424888e6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f3b7c3f-735e-46a2-a488-e5c3802e4633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_acc38ebb-93f8-48f8-a5e0-444d3472c4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f3b7c3f-735e-46a2-a488-e5c3802e4633" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_acc38ebb-93f8-48f8-a5e0-444d3472c4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_2e15b71e-c8e6-42cb-9817-c32ca025c70c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f3b7c3f-735e-46a2-a488-e5c3802e4633" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_2e15b71e-c8e6-42cb-9817-c32ca025c70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_c40c0274-1b17-4432-b550-04d63f546acf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f3b7c3f-735e-46a2-a488-e5c3802e4633" xlink:to="loc_us-gaap_ComputerEquipmentMember_c40c0274-1b17-4432-b550-04d63f546acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_SoftwareMember_e0351d19-1dbe-467c-90b6-cd02c3708115" xlink:href="xfor-20240331.xsd#xfor_SoftwareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f3b7c3f-735e-46a2-a488-e5c3802e4633" xlink:to="loc_xfor_SoftwareMember_e0351d19-1dbe-467c-90b6-cd02c3708115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LabEquipmentMember_4508168a-c0e8-4e27-89c1-8e63e5d2c80c" xlink:href="xfor-20240331.xsd#xfor_LabEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f3b7c3f-735e-46a2-a488-e5c3802e4633" xlink:to="loc_xfor_LabEquipmentMember_4508168a-c0e8-4e27-89c1-8e63e5d2c80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9677f1d-ad50-4000-b617-ac7baf99b842" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b4a7d96e-bc0f-4b42-a2c5-41cf3ef3a6a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9677f1d-ad50-4000-b617-ac7baf99b842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_83bbaf68-06e2-4e49-ad8d-8838cf53f707" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9677f1d-ad50-4000-b617-ac7baf99b842" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_83bbaf68-06e2-4e49-ad8d-8838cf53f707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_653fba48-9bf7-46b4-a487-7341d3cdbffc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9677f1d-ad50-4000-b617-ac7baf99b842" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_653fba48-9bf7-46b4-a487-7341d3cdbffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b6dda1ad-ab6a-4f98-a4f2-f5fd684c7426" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9677f1d-ad50-4000-b617-ac7baf99b842" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b6dda1ad-ab6a-4f98-a4f2-f5fd684c7426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/PropertyandEquipmentNetAdditionalInformationDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#PropertyandEquipmentNetAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/PropertyandEquipmentNetAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_4f99466a-06da-45e4-a665-8b0461c3b4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4ee5a93f-67d1-4b68-ae1a-daf97430d479" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_4f99466a-06da-45e4-a665-8b0461c3b4e9" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4ee5a93f-67d1-4b68-ae1a-daf97430d479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/AccruedExpensesScheduleofAccruedExpensesDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#AccruedExpensesScheduleofAccruedExpensesDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/AccruedExpensesScheduleofAccruedExpensesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_cb47cb9e-0c4c-4abf-8877-a5307b0a2305" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d80bc8d2-7bf9-412a-a4ea-9df1bc9e8bae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_cb47cb9e-0c4c-4abf-8877-a5307b0a2305" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d80bc8d2-7bf9-412a-a4ea-9df1bc9e8bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AccruedExternalResearchAndDevelopmentExpenses_7371b862-1581-453b-9d72-31ec933e5be0" xlink:href="xfor-20240331.xsd#xfor_AccruedExternalResearchAndDevelopmentExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_cb47cb9e-0c4c-4abf-8877-a5307b0a2305" xlink:to="loc_xfor_AccruedExternalResearchAndDevelopmentExpenses_7371b862-1581-453b-9d72-31ec933e5be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_21beac34-f9fa-43f8-bd18-1412aaed245f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_cb47cb9e-0c4c-4abf-8877-a5307b0a2305" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_21beac34-f9fa-43f8-bd18-1412aaed245f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_84e9377f-8697-4d71-ba4d-dd523af09023" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_cb47cb9e-0c4c-4abf-8877-a5307b0a2305" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_84e9377f-8697-4d71-ba4d-dd523af09023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9245bea5-2cee-4c1a-b026-4a5b9fa07a82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_cb47cb9e-0c4c-4abf-8877-a5307b0a2305" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9245bea5-2cee-4c1a-b026-4a5b9fa07a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LongTermDebtSummaryofLongTermDebtDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#LongTermDebtSummaryofLongTermDebtDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LongTermDebtSummaryofLongTermDebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2209b0d1-baa4-41c6-9c1a-3ec708e54ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_0a814c88-61e0-4c48-a93f-c2cc6fac6d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2209b0d1-baa4-41c6-9c1a-3ec708e54ff3" xlink:to="loc_us-gaap_LongTermDebt_0a814c88-61e0-4c48-a93f-c2cc6fac6d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_96f0bad2-5b88-4079-9d45-dea8719155ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2209b0d1-baa4-41c6-9c1a-3ec708e54ff3" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_96f0bad2-5b88-4079-9d45-dea8719155ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AccretionOnLongTermDebt_0310a410-a560-4f8b-af3e-582ef8f6a94a" xlink:href="xfor-20240331.xsd#xfor_AccretionOnLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2209b0d1-baa4-41c6-9c1a-3ec708e54ff3" xlink:to="loc_xfor_AccretionOnLongTermDebt_0310a410-a560-4f8b-af3e-582ef8f6a94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LongTermDebtIncludingAccretion_82bcafef-6368-4cf1-96b4-230fdfafa358" xlink:href="xfor-20240331.xsd#xfor_LongTermDebtIncludingAccretion"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2209b0d1-baa4-41c6-9c1a-3ec708e54ff3" xlink:to="loc_xfor_LongTermDebtIncludingAccretion_82bcafef-6368-4cf1-96b4-230fdfafa358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LongTermDebtHerculesLoanAgreementAdditionalInformationDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#LongTermDebtHerculesLoanAgreementAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LongTermDebtHerculesLoanAgreementAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fcf4e6cf-bfe1-4034-bdcc-fe83b2055f48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_53ffe645-c82f-40c0-9325-ddb0085b1200" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fcf4e6cf-bfe1-4034-bdcc-fe83b2055f48" xlink:to="loc_us-gaap_DebtInstrumentTable_53ffe645-c82f-40c0-9325-ddb0085b1200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e1d675f1-71a0-49fe-9650-685779e64cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_53ffe645-c82f-40c0-9325-ddb0085b1200" xlink:to="loc_us-gaap_DebtInstrumentAxis_e1d675f1-71a0-49fe-9650-685779e64cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6a4cb99c-ad32-4574-b64f-b68c35a54226" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e1d675f1-71a0-49fe-9650-685779e64cc6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6a4cb99c-ad32-4574-b64f-b68c35a54226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_HerculesLoanAgreementMember_b59fd758-3750-496d-b73b-eea2079ec9ca" xlink:href="xfor-20240331.xsd#xfor_HerculesLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6a4cb99c-ad32-4574-b64f-b68c35a54226" xlink:to="loc_xfor_HerculesLoanAgreementMember_b59fd758-3750-496d-b73b-eea2079ec9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_HerculesSecondAmendedLoanAgreementMember_8f9762d3-6e0d-4b06-bce3-83138b2a7ad3" xlink:href="xfor-20240331.xsd#xfor_HerculesSecondAmendedLoanAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6a4cb99c-ad32-4574-b64f-b68c35a54226" xlink:to="loc_xfor_HerculesSecondAmendedLoanAgreementMember_8f9762d3-6e0d-4b06-bce3-83138b2a7ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_89bbad28-126c-4206-8a03-42c1122428e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_53ffe645-c82f-40c0-9325-ddb0085b1200" xlink:to="loc_us-gaap_VariableRateAxis_89bbad28-126c-4206-8a03-42c1122428e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_36601720-9245-4c57-8d20-f091139d04aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_89bbad28-126c-4206-8a03-42c1122428e2" xlink:to="loc_us-gaap_VariableRateDomain_36601720-9245-4c57-8d20-f091139d04aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_d0934366-23c7-439d-8e81-79c8fad8ffe8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_36601720-9245-4c57-8d20-f091139d04aa" xlink:to="loc_us-gaap_PrimeRateMember_d0934366-23c7-439d-8e81-79c8fad8ffe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_423fd781-c2b0-42f9-844d-73be8a743090" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_53ffe645-c82f-40c0-9325-ddb0085b1200" xlink:to="loc_srt_RangeAxis_423fd781-c2b0-42f9-844d-73be8a743090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2f8f2980-43b7-4ade-b3a5-3ff2fee20697" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_423fd781-c2b0-42f9-844d-73be8a743090" xlink:to="loc_srt_RangeMember_2f8f2980-43b7-4ade-b3a5-3ff2fee20697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1865780a-f635-4042-bb7d-066550fe1eb8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2f8f2980-43b7-4ade-b3a5-3ff2fee20697" xlink:to="loc_srt_MaximumMember_1865780a-f635-4042-bb7d-066550fe1eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1db12029-63e8-4eab-ac90-d84fac61a787" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_53ffe645-c82f-40c0-9325-ddb0085b1200" xlink:to="loc_us-gaap_CreditFacilityAxis_1db12029-63e8-4eab-ac90-d84fac61a787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_78bbb4d3-f321-44c2-8716-3063691447d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1db12029-63e8-4eab-ac90-d84fac61a787" xlink:to="loc_us-gaap_CreditFacilityDomain_78bbb4d3-f321-44c2-8716-3063691447d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_MinCashTestDate1Member_d37c468b-480e-4619-b010-c78f3e889314" xlink:href="xfor-20240331.xsd#xfor_MinCashTestDate1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_78bbb4d3-f321-44c2-8716-3063691447d8" xlink:to="loc_xfor_MinCashTestDate1Member_d37c468b-480e-4619-b010-c78f3e889314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_6f207066-a9f8-46c3-8d18-5ca18b9c2b92" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_53ffe645-c82f-40c0-9325-ddb0085b1200" xlink:to="loc_srt_StatementScenarioAxis_6f207066-a9f8-46c3-8d18-5ca18b9c2b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0b64fe44-40a9-46ca-954d-e1cb8a4d93a0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_6f207066-a9f8-46c3-8d18-5ca18b9c2b92" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0b64fe44-40a9-46ca-954d-e1cb8a4d93a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_b1a13596-0b8c-4dcf-96ed-4db2de5a4ac4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_0b64fe44-40a9-46ca-954d-e1cb8a4d93a0" xlink:to="loc_srt_ScenarioForecastMember_b1a13596-0b8c-4dcf-96ed-4db2de5a4ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_55ae160a-0c40-4d1c-a26a-2aa149ee5f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_53ffe645-c82f-40c0-9325-ddb0085b1200" xlink:to="loc_us-gaap_VestingAxis_55ae160a-0c40-4d1c-a26a-2aa149ee5f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_5656c67d-978d-4cd0-9298-34f2697dc654" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_55ae160a-0c40-4d1c-a26a-2aa149ee5f9c" xlink:to="loc_us-gaap_VestingDomain_5656c67d-978d-4cd0-9298-34f2697dc654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_87d01d08-c674-4552-92cd-e39a3cabe324" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_5656c67d-978d-4cd0-9298-34f2697dc654" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_87d01d08-c674-4552-92cd-e39a3cabe324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_e84f2eff-a6ff-4ce2-9468-8e4896d99db9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_5656c67d-978d-4cd0-9298-34f2697dc654" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_e84f2eff-a6ff-4ce2-9468-8e4896d99db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_6ae68dfd-26d4-40e7-891c-432b26a501d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_5656c67d-978d-4cd0-9298-34f2697dc654" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_6ae68dfd-26d4-40e7-891c-432b26a501d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_41cc1e11-03f6-41cc-aafa-77f1adfe0d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_53ffe645-c82f-40c0-9325-ddb0085b1200" xlink:to="loc_us-gaap_DebtInstrumentLineItems_41cc1e11-03f6-41cc-aafa-77f1adfe0d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_c533e7c5-ed82-472d-9b1c-715e2215d73b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41cc1e11-03f6-41cc-aafa-77f1adfe0d8a" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_c533e7c5-ed82-472d-9b1c-715e2215d73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_643e6eb8-39fb-43ca-9860-cdfddcea1ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41cc1e11-03f6-41cc-aafa-77f1adfe0d8a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_643e6eb8-39fb-43ca-9860-cdfddcea1ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_bb87e086-4ffd-4ba8-9de9-c27d4f74f95c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41cc1e11-03f6-41cc-aafa-77f1adfe0d8a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_bb87e086-4ffd-4ba8-9de9-c27d4f74f95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityPeriodicPayment_b095172d-600f-464d-b0de-4f6c27247af2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityPeriodicPayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41cc1e11-03f6-41cc-aafa-77f1adfe0d8a" xlink:to="loc_us-gaap_LineOfCreditFacilityPeriodicPayment_b095172d-600f-464d-b0de-4f6c27247af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LineOfCreditCovenantMinimumCash_fd5d1974-d543-49d4-b2b9-96a1c00e79e4" xlink:href="xfor-20240331.xsd#xfor_LineOfCreditCovenantMinimumCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41cc1e11-03f6-41cc-aafa-77f1adfe0d8a" xlink:to="loc_xfor_LineOfCreditCovenantMinimumCash_fd5d1974-d543-49d4-b2b9-96a1c00e79e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_903eb520-8e42-4c5d-ad2e-99cb5101906b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41cc1e11-03f6-41cc-aafa-77f1adfe0d8a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_903eb520-8e42-4c5d-ad2e-99cb5101906b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_3f4e1f9a-11b2-4407-92bf-a251797ca7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41cc1e11-03f6-41cc-aafa-77f1adfe0d8a" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_3f4e1f9a-11b2-4407-92bf-a251797ca7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a2e2069a-1451-47cf-82d4-b7abe6ace118" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41cc1e11-03f6-41cc-aafa-77f1adfe0d8a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a2e2069a-1451-47cf-82d4-b7abe6ace118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LongTermDebtSummaryofInterestExpenseDetails" xlink:type="simple" xlink:href="xfor-20240331.xsd#LongTermDebtSummaryofInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LongTermDebtSummaryofInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_49d5953b-b2d0-4a2e-9c58-7e604a4dd8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b2028559-84e9-40d3-9d1d-9b864933e6b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_49d5953b-b2d0-4a2e-9c58-7e604a4dd8c5" xlink:to="loc_us-gaap_DebtInstrumentTable_b2028559-84e9-40d3-9d1d-9b864933e6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_21385aa8-7247-45a2-81d3-a0211ba0651f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b2028559-84e9-40d3-9d1d-9b864933e6b2" xlink:to="loc_us-gaap_DebtInstrumentAxis_21385aa8-7247-45a2-81d3-a0211ba0651f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5c6a4292-f486-4c34-b01f-619ba1acf08c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_21385aa8-7247-45a2-81d3-a0211ba0651f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5c6a4292-f486-4c34-b01f-619ba1acf08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_HerculesLoanAgreementMember_fc034311-f10b-4152-a3df-7f597e08015a" xlink:href="xfor-20240331.xsd#xfor_HerculesLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5c6a4292-f486-4c34-b01f-619ba1acf08c" xlink:to="loc_xfor_HerculesLoanAgreementMember_fc034311-f10b-4152-a3df-7f597e08015a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_741e69a2-f512-4d9d-824f-635bdeb907d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b2028559-84e9-40d3-9d1d-9b864933e6b2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_741e69a2-f512-4d9d-824f-635bdeb907d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_03555674-6c00-42c6-a384-6519ec780383" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_741e69a2-f512-4d9d-824f-635bdeb907d6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_03555674-6c00-42c6-a384-6519ec780383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_482f4dc1-db60-465b-aca8-63a4f59fa9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b2028559-84e9-40d3-9d1d-9b864933e6b2" xlink:to="loc_us-gaap_VariableRateAxis_482f4dc1-db60-465b-aca8-63a4f59fa9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2455ffe7-f3fd-4fe8-81e9-fe4e72b60b18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_482f4dc1-db60-465b-aca8-63a4f59fa9a1" xlink:to="loc_us-gaap_VariableRateDomain_2455ffe7-f3fd-4fe8-81e9-fe4e72b60b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3e3fe38c-af23-47c2-abf1-7604a4d5dd18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b2028559-84e9-40d3-9d1d-9b864933e6b2" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3e3fe38c-af23-47c2-abf1-7604a4d5dd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_c4e377d6-b2e9-4823-a429-98831172cd03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3e3fe38c-af23-47c2-abf1-7604a4d5dd18" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_c4e377d6-b2e9-4823-a429-98831172cd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e171c731-b54f-4099-81df-fd7ac0438278" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b2028559-84e9-40d3-9d1d-9b864933e6b2" xlink:to="loc_srt_RangeAxis_e171c731-b54f-4099-81df-fd7ac0438278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a2de3a14-51f8-446f-a3aa-ca06c223f015" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e171c731-b54f-4099-81df-fd7ac0438278" xlink:to="loc_srt_RangeMember_a2de3a14-51f8-446f-a3aa-ca06c223f015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7c1df59d-a63c-4982-b3c1-c9e109eaf42d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b2028559-84e9-40d3-9d1d-9b864933e6b2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7c1df59d-a63c-4982-b3c1-c9e109eaf42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_5fa92876-65ca-4091-8d42-c81146334d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c1df59d-a63c-4982-b3c1-c9e109eaf42d" xlink:to="loc_us-gaap_InterestExpenseDebt_5fa92876-65ca-4091-8d42-c81146334d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_b719f8c5-62f3-42f1-8f7f-11f8f4a2eaea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c1df59d-a63c-4982-b3c1-c9e109eaf42d" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_b719f8c5-62f3-42f1-8f7f-11f8f4a2eaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LongTermDebtScheduleofFuturePrincipalPaymentsandtheFinalPaymentsDueDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#LongTermDebtScheduleofFuturePrincipalPaymentsandtheFinalPaymentsDueDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LongTermDebtScheduleofFuturePrincipalPaymentsandtheFinalPaymentsDueDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_003b5f0b-9a1a-4592-b1d1-d21671d3ca97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_c282427c-0391-4a5b-be26-110fab35df57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_003b5f0b-9a1a-4592-b1d1-d21671d3ca97" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_c282427c-0391-4a5b-be26-110fab35df57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_7fa0c3f1-c9dd-4393-99d8-7de19d45290e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_003b5f0b-9a1a-4592-b1d1-d21671d3ca97" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_7fa0c3f1-c9dd-4393-99d8-7de19d45290e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3a923ff6-7534-4d8b-babf-86b3576e7455" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_003b5f0b-9a1a-4592-b1d1-d21671d3ca97" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3a923ff6-7534-4d8b-babf-86b3576e7455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LongTermDebtAndEOTPayment_6d553b86-21da-4864-9665-79a27e726181" xlink:href="xfor-20240331.xsd#xfor_LongTermDebtAndEOTPayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_003b5f0b-9a1a-4592-b1d1-d21671d3ca97" xlink:to="loc_xfor_LongTermDebtAndEOTPayment_6d553b86-21da-4864-9665-79a27e726181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LeasesAdditionalInformationDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#LeasesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LeasesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cbfd0bf4-be3a-4358-a105-f82b54014950" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_56a2bd2f-9913-41c5-af69-8644fc98ea56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cbfd0bf4-be3a-4358-a105-f82b54014950" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_56a2bd2f-9913-41c5-af69-8644fc98ea56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_f821b6cd-ba6d-4fe2-9072-557f3070e0c9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_56a2bd2f-9913-41c5-af69-8644fc98ea56" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_f821b6cd-ba6d-4fe2-9072-557f3070e0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_68e4e00c-84dc-478c-bee8-ef611400b8b9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_f821b6cd-ba6d-4fe2-9072-557f3070e0c9" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_68e4e00c-84dc-478c-bee8-ef611400b8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_WalthamLeaseMember_bdbc114d-b4a9-417d-a19d-a481d7be74c6" xlink:href="xfor-20240331.xsd#xfor_WalthamLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_68e4e00c-84dc-478c-bee8-ef611400b8b9" xlink:to="loc_xfor_WalthamLeaseMember_bdbc114d-b4a9-417d-a19d-a481d7be74c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ViennaAustriaLeaseMember_f37af296-1dcc-40ec-b5da-45c9a9b1c3a8" xlink:href="xfor-20240331.xsd#xfor_ViennaAustriaLeaseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_68e4e00c-84dc-478c-bee8-ef611400b8b9" xlink:to="loc_xfor_ViennaAustriaLeaseMember_f37af296-1dcc-40ec-b5da-45c9a9b1c3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_AllstonLeaseMember_be0ff511-fbb3-4e48-a416-498c07d51d30" xlink:href="xfor-20240331.xsd#xfor_AllstonLeaseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_68e4e00c-84dc-478c-bee8-ef611400b8b9" xlink:to="loc_xfor_AllstonLeaseMember_be0ff511-fbb3-4e48-a416-498c07d51d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_86ca1566-c703-4c22-960c-93c15b893343" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_56a2bd2f-9913-41c5-af69-8644fc98ea56" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_86ca1566-c703-4c22-960c-93c15b893343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LesseeOperatingLeaseLeaseNotYetCommencedOfficeSpace_2223e4e5-0e7e-43aa-91b2-0fe3e2b6c82c" xlink:href="xfor-20240331.xsd#xfor_LesseeOperatingLeaseLeaseNotYetCommencedOfficeSpace"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86ca1566-c703-4c22-960c-93c15b893343" xlink:to="loc_xfor_LesseeOperatingLeaseLeaseNotYetCommencedOfficeSpace_2223e4e5-0e7e-43aa-91b2-0fe3e2b6c82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_758cd921-f1f3-4867-b208-40addd9d264a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86ca1566-c703-4c22-960c-93c15b893343" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_758cd921-f1f3-4867-b208-40addd9d264a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LesseeOperatingLeaseLeaseNotYetCommencedAnnualBaseRent_2c2c6f18-6c01-4f45-abb1-3475d795a644" xlink:href="xfor-20240331.xsd#xfor_LesseeOperatingLeaseLeaseNotYetCommencedAnnualBaseRent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86ca1566-c703-4c22-960c-93c15b893343" xlink:to="loc_xfor_LesseeOperatingLeaseLeaseNotYetCommencedAnnualBaseRent_2c2c6f18-6c01-4f45-abb1-3475d795a644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LesseeOperatingLeaseLeaseNotYetCommencedAmount_6770c287-4f6e-412a-8b08-9d503a65c939" xlink:href="xfor-20240331.xsd#xfor_LesseeOperatingLeaseLeaseNotYetCommencedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86ca1566-c703-4c22-960c-93c15b893343" xlink:to="loc_xfor_LesseeOperatingLeaseLeaseNotYetCommencedAmount_6770c287-4f6e-412a-8b08-9d503a65c939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ac32e9a5-7dd4-48e1-80db-e7c4efbfe5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86ca1566-c703-4c22-960c-93c15b893343" xlink:to="loc_us-gaap_OperatingLeaseLiability_ac32e9a5-7dd4-48e1-80db-e7c4efbfe5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_cf4c1a76-745a-429e-9fe0-07b02c3e22a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86ca1566-c703-4c22-960c-93c15b893343" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_cf4c1a76-745a-429e-9fe0-07b02c3e22a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LeasesScheduleofComponentsofLeaseExpenseDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#LeasesScheduleofComponentsofLeaseExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LeasesScheduleofComponentsofLeaseExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_08699fe5-c322-4a46-b572-1d80e7c3342e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_3e96a8a1-51d5-43b1-920e-f014bb9bd996" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_08699fe5-c322-4a46-b572-1d80e7c3342e" xlink:to="loc_us-gaap_OperatingLeaseCost_3e96a8a1-51d5-43b1-920e-f014bb9bd996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_4e443f04-bd90-4e6a-b9e6-4b18884cff59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_08699fe5-c322-4a46-b572-1d80e7c3342e" xlink:to="loc_us-gaap_LeaseCost_4e443f04-bd90-4e6a-b9e6-4b18884cff59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_46cd4d7d-7ef8-4abb-b6d7-77dfa6ac0ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_08699fe5-c322-4a46-b572-1d80e7c3342e" xlink:to="loc_us-gaap_OperatingLeasePayments_46cd4d7d-7ef8-4abb-b6d7-77dfa6ac0ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_bd484b53-4fef-48e9-b97c-231cffc4f8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_08699fe5-c322-4a46-b572-1d80e7c3342e" xlink:to="loc_us-gaap_SubleaseIncome_bd484b53-4fef-48e9-b97c-231cffc4f8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4c1307f8-9173-4b9c-af39-8b42b314c765" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_08699fe5-c322-4a46-b572-1d80e7c3342e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4c1307f8-9173-4b9c-af39-8b42b314c765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_275788bc-c7a6-49fb-9b31-f3612d2221cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_08699fe5-c322-4a46-b572-1d80e7c3342e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_275788bc-c7a6-49fb-9b31-f3612d2221cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8d0992d6-c16d-428d-b620-3d97c6afd1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_209f6d14-bffb-40d7-b2b8-b00cb61bee49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8d0992d6-c16d-428d-b620-3d97c6afd1d0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_209f6d14-bffb-40d7-b2b8-b00cb61bee49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4120a189-de9f-4614-b6ee-4c990893a0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8d0992d6-c16d-428d-b620-3d97c6afd1d0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4120a189-de9f-4614-b6ee-4c990893a0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2641c60c-2d2a-4089-9e4c-f457120a2abc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8d0992d6-c16d-428d-b620-3d97c6afd1d0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2641c60c-2d2a-4089-9e4c-f457120a2abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4f57bdec-ba36-4ccd-ae07-bbd779d2b41f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8d0992d6-c16d-428d-b620-3d97c6afd1d0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4f57bdec-ba36-4ccd-ae07-bbd779d2b41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4556dc83-094c-4d0e-bf10-18fa51bf5424" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8d0992d6-c16d-428d-b620-3d97c6afd1d0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4556dc83-094c-4d0e-bf10-18fa51bf5424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8553219d-8cd3-413c-9412-a97d12886e24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8d0992d6-c16d-428d-b620-3d97c6afd1d0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8553219d-8cd3-413c-9412-a97d12886e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_60667877-956c-418b-9dea-9188dd5e5cba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8d0992d6-c16d-428d-b620-3d97c6afd1d0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_60667877-956c-418b-9dea-9188dd5e5cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_22ca9883-a091-4edd-8f0c-de401f339e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8d0992d6-c16d-428d-b620-3d97c6afd1d0" xlink:to="loc_us-gaap_OperatingLeaseLiability_22ca9883-a091-4edd-8f0c-de401f339e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/CommitmentandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#CommitmentandContingenciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CommitmentandContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_249b2ee9-412c-496b-bfc3-d740bb5c1bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ContingenciesAndCommitmentsTable_74335f9b-0619-446e-8fc9-51afa6881628" xlink:href="xfor-20240331.xsd#xfor_ContingenciesAndCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_249b2ee9-412c-496b-bfc3-d740bb5c1bbd" xlink:to="loc_xfor_ContingenciesAndCommitmentsTable_74335f9b-0619-446e-8fc9-51afa6881628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_9006955f-a7cf-43bc-825b-2871dd5809c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_ContingenciesAndCommitmentsTable_74335f9b-0619-446e-8fc9-51afa6881628" xlink:to="loc_us-gaap_TypeOfArrangementAxis_9006955f-a7cf-43bc-825b-2871dd5809c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4c6d8f5a-c674-4867-8a01-3cd0ef37158a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9006955f-a7cf-43bc-825b-2871dd5809c9" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4c6d8f5a-c674-4867-8a01-3cd0ef37158a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IndemnificationAgreementsMember_8614cff4-b9ad-44ed-a31a-59ab451f4cb3" xlink:href="xfor-20240331.xsd#xfor_IndemnificationAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4c6d8f5a-c674-4867-8a01-3cd0ef37158a" xlink:to="loc_xfor_IndemnificationAgreementsMember_8614cff4-b9ad-44ed-a31a-59ab451f4cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ContingenciesAndCommitmentsLineItems_703def84-0a77-4589-b4f9-07c44e4aeb31" xlink:href="xfor-20240331.xsd#xfor_ContingenciesAndCommitmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_ContingenciesAndCommitmentsTable_74335f9b-0619-446e-8fc9-51afa6881628" xlink:to="loc_xfor_ContingenciesAndCommitmentsLineItems_703def84-0a77-4589-b4f9-07c44e4aeb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_faee88c5-f0b0-46de-85b1-b60d6630ad80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_ContingenciesAndCommitmentsLineItems_703def84-0a77-4589-b4f9-07c44e4aeb31" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_faee88c5-f0b0-46de-85b1-b60d6630ad80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_614262a8-a8b8-4e46-a1d4-66e5a0c76299" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_ContingenciesAndCommitmentsLineItems_703def84-0a77-4589-b4f9-07c44e4aeb31" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_614262a8-a8b8-4e46-a1d4-66e5a0c76299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/CommonStockWarrantsAdditionalInformationDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#CommonStockWarrantsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CommonStockWarrantsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1e192fd8-50ef-4f05-8f93-0ff05e902fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_c77451cb-b2ad-4c51-b529-61424091c58f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1e192fd8-50ef-4f05-8f93-0ff05e902fb0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_c77451cb-b2ad-4c51-b529-61424091c58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2c1db053-c15e-4436-966f-172d5cbc3e97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c77451cb-b2ad-4c51-b529-61424091c58f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2c1db053-c15e-4436-966f-172d5cbc3e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_262b4118-3746-4ed7-a88c-aeee41a2256e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2c1db053-c15e-4436-966f-172d5cbc3e97" xlink:to="loc_us-gaap_EquityComponentDomain_262b4118-3746-4ed7-a88c-aeee41a2256e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_Q12022PrivatePlacementMember_caced750-e28b-49b3-9525-f0da691381cd" xlink:href="xfor-20240331.xsd#xfor_Q12022PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_262b4118-3746-4ed7-a88c-aeee41a2256e" xlink:to="loc_xfor_Q12022PrivatePlacementMember_caced750-e28b-49b3-9525-f0da691381cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_a2f19236-6938-4216-b09e-e8c2a8a7424c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c77451cb-b2ad-4c51-b529-61424091c58f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_a2f19236-6938-4216-b09e-e8c2a8a7424c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_bd8d0759-8ac7-455b-bcca-a457fc0cfe13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a2f19236-6938-4216-b09e-e8c2a8a7424c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_bd8d0759-8ac7-455b-bcca-a457fc0cfe13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_472d0743-51e4-4694-95ec-cd8789aef28a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a2f19236-6938-4216-b09e-e8c2a8a7424c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_472d0743-51e4-4694-95ec-cd8789aef28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_81f14daf-5ad3-42ae-8609-e379e6aa9608" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a2f19236-6938-4216-b09e-e8c2a8a7424c" xlink:to="loc_us-gaap_DividendsCommonStock_81f14daf-5ad3-42ae-8609-e379e6aa9608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights_e0aaf046-d3dc-4716-8ade-47ff871856ca" xlink:href="xfor-20240331.xsd#xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a2f19236-6938-4216-b09e-e8c2a8a7424c" xlink:to="loc_xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights_e0aaf046-d3dc-4716-8ade-47ff871856ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/CommonStockWarrantsSummaryofOutstandingWarrantstoPurchaseSharesofCommonStockDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#CommonStockWarrantsSummaryofOutstandingWarrantstoPurchaseSharesofCommonStockDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/CommonStockWarrantsSummaryofOutstandingWarrantstoPurchaseSharesofCommonStockDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7139b2a4-474d-4aab-a71c-2c117caec5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_c46d7823-2ab3-48dd-a455-9902666af0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7139b2a4-474d-4aab-a71c-2c117caec5ac" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_c46d7823-2ab3-48dd-a455-9902666af0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_51c53c6e-82f2-46d9-8f77-a81c91873d91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c46d7823-2ab3-48dd-a455-9902666af0ed" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_51c53c6e-82f2-46d9-8f77-a81c91873d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_51c53c6e-82f2-46d9-8f77-a81c91873d91" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnOctoberTwentyFiveTwoThousandSixteenMember_c2f39a06-901a-4075-a310-128f7004712c" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnOctoberTwentyFiveTwoThousandSixteenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnOctoberTwentyFiveTwoThousandSixteenMember_c2f39a06-901a-4075-a310-128f7004712c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnDecemberTwentyEightTwoThousandSeventeenOneMember_0042274a-f62f-4c81-8b8e-78d37bed9d4f" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnDecemberTwentyEightTwoThousandSeventeenOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnDecemberTwentyEightTwoThousandSeventeenOneMember_0042274a-f62f-4c81-8b8e-78d37bed9d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnSeptemberTwelveTwoThousandEighteenOneMember_98746ce0-3caa-4af7-9c2d-953b93044527" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnSeptemberTwelveTwoThousandEighteenOneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnSeptemberTwelveTwoThousandEighteenOneMember_98746ce0-3caa-4af7-9c2d-953b93044527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnOctoberNineteenTwoThousandEighteenMember_b9a23bbb-c458-405c-88b9-7aa865cf9093" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnOctoberNineteenTwoThousandEighteenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnOctoberNineteenTwoThousandEighteenMember_b9a23bbb-c458-405c-88b9-7aa865cf9093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnMarchThirteenTwoThousandNineteenMember_b70021a8-a4e2-46b1-9983-b25a7dd6a400" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnMarchThirteenTwoThousandNineteenMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnMarchThirteenTwoThousandNineteenMember_b70021a8-a4e2-46b1-9983-b25a7dd6a400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnAprilSixteenTwoThousandNineteenMember_5a122ac6-161b-433a-b577-516692546c49" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnAprilSixteenTwoThousandNineteenMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnAprilSixteenTwoThousandNineteenMember_5a122ac6-161b-433a-b577-516692546c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnNovemberTwentyNineTwoThousandNineteenOneMember_e36c3670-a5d6-47bf-ad67-abbc2736fa8f" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnNovemberTwentyNineTwoThousandNineteenOneMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnNovemberTwentyNineTwoThousandNineteenOneMember_e36c3670-a5d6-47bf-ad67-abbc2736fa8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnMarch232021Member_84d158ea-13d6-4bf2-9547-825b34391044" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnMarch232021Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnMarch232021Member_84d158ea-13d6-4bf2-9547-825b34391044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PreFundedWarrantMember_6b4e7d4a-cd87-412d-8edb-cffd4c4114b0" xlink:href="xfor-20240331.xsd#xfor_PreFundedWarrantMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_PreFundedWarrantMember_6b4e7d4a-cd87-412d-8edb-cffd4c4114b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnNovemberNineTwoThousandTwentyOneMember_83439d32-f01f-47fb-a27a-c40f635ed727" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnNovemberNineTwoThousandTwentyOneMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnNovemberNineTwoThousandTwentyOneMember_83439d32-f01f-47fb-a27a-c40f635ed727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnMarch32022Member_186e12bd-0f8f-4357-b36d-175c6877c24f" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnMarch32022Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnMarch32022Member_186e12bd-0f8f-4357-b36d-175c6877c24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnJuly20221Member_2a8b980b-3010-494d-8f38-33b73afc3512" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnJuly20221Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnJuly20221Member_2a8b980b-3010-494d-8f38-33b73afc3512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnJuly620222Member_68db7526-a667-44bd-95f6-e6434a7b3cdb" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnJuly620222Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnJuly620222Member_68db7526-a667-44bd-95f6-e6434a7b3cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnDecember92022Member_cee54056-3146-4700-b214-6d9bd156e665" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnDecember92022Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnDecember92022Member_cee54056-3146-4700-b214-6d9bd156e665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnDecember920222Member_3a0c0803-844d-4a3c-a16f-b0adcbd1693d" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnDecember920222Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnDecember920222Member_3a0c0803-844d-4a3c-a16f-b0adcbd1693d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_IssuanceOnMay192023Member_7c394a1b-0ce5-42d6-99fd-0af8867d49e8" xlink:href="xfor-20240331.xsd#xfor_IssuanceOnMay192023Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3678fa22-c762-4934-9856-205a02e86952" xlink:to="loc_xfor_IssuanceOnMay192023Member_7c394a1b-0ce5-42d6-99fd-0af8867d49e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9b00601c-b971-4876-88d0-9ea281b2f7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c46d7823-2ab3-48dd-a455-9902666af0ed" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9b00601c-b971-4876-88d0-9ea281b2f7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5a567a9e-07f8-4a49-859d-1afb2e4023c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9b00601c-b971-4876-88d0-9ea281b2f7d0" xlink:to="loc_us-gaap_EquityComponentDomain_5a567a9e-07f8-4a49-859d-1afb2e4023c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PreFundedWarrantMember_d878004a-3f42-492c-b1e3-36ef0f485deb" xlink:href="xfor-20240331.xsd#xfor_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5a567a9e-07f8-4a49-859d-1afb2e4023c6" xlink:to="loc_xfor_PreFundedWarrantMember_d878004a-3f42-492c-b1e3-36ef0f485deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassAWarrantMember_42b2ce3e-729f-48a8-9f1d-8034ed68dcc0" xlink:href="xfor-20240331.xsd#xfor_ClassAWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5a567a9e-07f8-4a49-859d-1afb2e4023c6" xlink:to="loc_xfor_ClassAWarrantMember_42b2ce3e-729f-48a8-9f1d-8034ed68dcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_LegacyWarrantsMember_b727efd5-d465-47ae-a0aa-944597e0a62c" xlink:href="xfor-20240331.xsd#xfor_LegacyWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5a567a9e-07f8-4a49-859d-1afb2e4023c6" xlink:to="loc_xfor_LegacyWarrantsMember_b727efd5-d465-47ae-a0aa-944597e0a62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PrefundedWarrantsAxis_4f98c294-e012-4a64-8e16-4a079f968af8" xlink:href="xfor-20240331.xsd#xfor_PrefundedWarrantsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c46d7823-2ab3-48dd-a455-9902666af0ed" xlink:to="loc_xfor_PrefundedWarrantsAxis_4f98c294-e012-4a64-8e16-4a079f968af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PrefundedWarrantsDomain_b220e796-3a53-4586-88b6-79ee5ccab8fe" xlink:href="xfor-20240331.xsd#xfor_PrefundedWarrantsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_PrefundedWarrantsAxis_4f98c294-e012-4a64-8e16-4a079f968af8" xlink:to="loc_xfor_PrefundedWarrantsDomain_b220e796-3a53-4586-88b6-79ee5ccab8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_FundedMember_bf039282-aef4-4de8-9a48-62e89d6f8603" xlink:href="xfor-20240331.xsd#xfor_FundedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_PrefundedWarrantsDomain_b220e796-3a53-4586-88b6-79ee5ccab8fe" xlink:to="loc_xfor_FundedMember_bf039282-aef4-4de8-9a48-62e89d6f8603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_4034979e-db38-426d-9a66-483c82b9cfd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_c46d7823-2ab3-48dd-a455-9902666af0ed" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_4034979e-db38-426d-9a66-483c82b9cfd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_c9f69daf-7744-40cc-9c1e-385d6f31651f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_4034979e-db38-426d-9a66-483c82b9cfd7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_c9f69daf-7744-40cc-9c1e-385d6f31651f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_16b2044d-62a0-4230-9d96-51016aaf619c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_4034979e-db38-426d-9a66-483c82b9cfd7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_16b2044d-62a0-4230-9d96-51016aaf619c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightAggregateProceedsFromWarrantsIssued_f86accbc-ae4e-4864-bd13-308fe02004d9" xlink:href="xfor-20240331.xsd#xfor_ClassOfWarrantOrRightAggregateProceedsFromWarrantsIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_4034979e-db38-426d-9a66-483c82b9cfd7" xlink:to="loc_xfor_ClassOfWarrantOrRightAggregateProceedsFromWarrantsIssued_f86accbc-ae4e-4864-bd13-308fe02004d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights_d8bd734b-e8b0-4478-9a98-57a2d3dad660" xlink:href="xfor-20240331.xsd#xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_4034979e-db38-426d-9a66-483c82b9cfd7" xlink:to="loc_xfor_ClassOfWarrantOrRightAdditionalExercisePriceOfWarrantsOrRights_d8bd734b-e8b0-4478-9a98-57a2d3dad660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#StockBasedCompensationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eb5a18d9-1b35-485f-a969-9ba4025962c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f77eb6b-d8fa-4f43-9b7b-3c5e960a178f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eb5a18d9-1b35-485f-a969-9ba4025962c0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f77eb6b-d8fa-4f43-9b7b-3c5e960a178f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3966fbf3-e348-4e70-ad5c-d332d5546221" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f77eb6b-d8fa-4f43-9b7b-3c5e960a178f" xlink:to="loc_us-gaap_PlanNameAxis_3966fbf3-e348-4e70-ad5c-d332d5546221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5dee38fa-b63d-45bd-9b90-4b73bbc2dee2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3966fbf3-e348-4e70-ad5c-d332d5546221" xlink:to="loc_us-gaap_PlanNameDomain_5dee38fa-b63d-45bd-9b90-4b73bbc2dee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_TwoThousandNineteenEquityIncentivePlanMember_8c63a9ed-4b45-4e1a-877c-cf8bcfc8a5b3" xlink:href="xfor-20240331.xsd#xfor_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_5dee38fa-b63d-45bd-9b90-4b73bbc2dee2" xlink:to="loc_xfor_TwoThousandNineteenEquityIncentivePlanMember_8c63a9ed-4b45-4e1a-877c-cf8bcfc8a5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_TwoThousandSeventeenEquityIncentivePlanMember_5edf66fb-9e6f-4c9a-9acd-4e381da7edc7" xlink:href="xfor-20240331.xsd#xfor_TwoThousandSeventeenEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_5dee38fa-b63d-45bd-9b90-4b73bbc2dee2" xlink:to="loc_xfor_TwoThousandSeventeenEquityIncentivePlanMember_5edf66fb-9e6f-4c9a-9acd-4e381da7edc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_52fa264c-9d15-4d86-b176-5517b14811bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f77eb6b-d8fa-4f43-9b7b-3c5e960a178f" xlink:to="loc_us-gaap_AwardTypeAxis_52fa264c-9d15-4d86-b176-5517b14811bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0eaa8ae5-dbfe-49b5-9e89-1d2d6c741880" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_52fa264c-9d15-4d86-b176-5517b14811bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0eaa8ae5-dbfe-49b5-9e89-1d2d6c741880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_baf2f807-6816-4060-8d6f-5e5eae62cc87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0eaa8ae5-dbfe-49b5-9e89-1d2d6c741880" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_baf2f807-6816-4060-8d6f-5e5eae62cc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36817528-bd49-473e-bf00-3497353d2f75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f77eb6b-d8fa-4f43-9b7b-3c5e960a178f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36817528-bd49-473e-bf00-3497353d2f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c58bbc32-a828-492c-b21e-20ba0dc46800" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36817528-bd49-473e-bf00-3497353d2f75" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c58bbc32-a828-492c-b21e-20ba0dc46800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardsGrantInPeriodWeightedAverageGrantDateFairValue_bc888b14-2a39-4790-bcde-6b06f2e02f2f" xlink:href="xfor-20240331.xsd#xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardsGrantInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36817528-bd49-473e-bf00-3497353d2f75" xlink:to="loc_xfor_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardsGrantInPeriodWeightedAverageGrantDateFairValue_bc888b14-2a39-4790-bcde-6b06f2e02f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ccadd054-f7d0-4907-bb46-670fe00f9a48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36817528-bd49-473e-bf00-3497353d2f75" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ccadd054-f7d0-4907-bb46-670fe00f9a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3949f64c-ab85-4221-b5b8-5a6b9c9c9c25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_36817528-bd49-473e-bf00-3497353d2f75" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3949f64c-ab85-4221-b5b8-5a6b9c9c9c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/StockBasedCompensationScheduleofAssumptionsUsedinBlackScholesOptionPricingModeltoDetermineGrantdateFairValueofStockOptionsGrantedDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#StockBasedCompensationScheduleofAssumptionsUsedinBlackScholesOptionPricingModeltoDetermineGrantdateFairValueofStockOptionsGrantedDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/StockBasedCompensationScheduleofAssumptionsUsedinBlackScholesOptionPricingModeltoDetermineGrantdateFairValueofStockOptionsGrantedDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04e31beb-039a-4fec-add3-cde9faf0e4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88d26ab8-70e0-4a42-99f7-ea7c9cbaa566" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04e31beb-039a-4fec-add3-cde9faf0e4d2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88d26ab8-70e0-4a42-99f7-ea7c9cbaa566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6e12c63d-c494-420a-ba5d-ebf060cf689e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88d26ab8-70e0-4a42-99f7-ea7c9cbaa566" xlink:to="loc_us-gaap_AwardTypeAxis_6e12c63d-c494-420a-ba5d-ebf060cf689e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1c1ad1d-67cb-4306-9249-ea2137cae27c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6e12c63d-c494-420a-ba5d-ebf060cf689e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1c1ad1d-67cb-4306-9249-ea2137cae27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_df3be275-28d8-4c91-a953-718811fce213" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1c1ad1d-67cb-4306-9249-ea2137cae27c" xlink:to="loc_us-gaap_WarrantMember_df3be275-28d8-4c91-a953-718811fce213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba7934c7-c633-46ca-9cfe-09da9c820e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88d26ab8-70e0-4a42-99f7-ea7c9cbaa566" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba7934c7-c633-46ca-9cfe-09da9c820e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_644b84ae-2509-43bb-a317-87e78fdbe975" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba7934c7-c633-46ca-9cfe-09da9c820e6c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_644b84ae-2509-43bb-a317-87e78fdbe975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_34ab65ca-2a48-458b-89f6-c1d875ec3cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba7934c7-c633-46ca-9cfe-09da9c820e6c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_34ab65ca-2a48-458b-89f6-c1d875ec3cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_56127ed9-61b0-4d5e-8019-a18546ad89fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba7934c7-c633-46ca-9cfe-09da9c820e6c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_56127ed9-61b0-4d5e-8019-a18546ad89fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0493c8de-e79c-4330-846b-b79ea847f1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba7934c7-c633-46ca-9cfe-09da9c820e6c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0493c8de-e79c-4330-846b-b79ea847f1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/StockBasedCompensationSummaryofStockOptionActivityDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#StockBasedCompensationSummaryofStockOptionActivityDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/StockBasedCompensationSummaryofStockOptionActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ab3360d-6410-4c7a-a4d1-ecb05fbd1394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_64e0acbd-59ec-43b8-8dc9-04de3065d51b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ab3360d-6410-4c7a-a4d1-ecb05fbd1394" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_64e0acbd-59ec-43b8-8dc9-04de3065d51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2693c5b2-72d6-4e18-a81d-49a536f208bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_64e0acbd-59ec-43b8-8dc9-04de3065d51b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2693c5b2-72d6-4e18-a81d-49a536f208bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_040301a0-4445-442e-ba95-9428b20bece6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_64e0acbd-59ec-43b8-8dc9-04de3065d51b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_040301a0-4445-442e-ba95-9428b20bece6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_04fccf0a-9cd5-4c35-afc0-149d7ff2f1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_64e0acbd-59ec-43b8-8dc9-04de3065d51b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_04fccf0a-9cd5-4c35-afc0-149d7ff2f1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_acc0ff7a-d177-49de-ac74-91b05e308ace" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_64e0acbd-59ec-43b8-8dc9-04de3065d51b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_acc0ff7a-d177-49de-ac74-91b05e308ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_bf38d5dd-132f-4426-bf9d-5495439f922e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ab3360d-6410-4c7a-a4d1-ecb05fbd1394" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_bf38d5dd-132f-4426-bf9d-5495439f922e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_eaccf66b-cde3-461c-8de3-fb9f9f667e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ab3360d-6410-4c7a-a4d1-ecb05fbd1394" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_eaccf66b-cde3-461c-8de3-fb9f9f667e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08cbbc4f-f0be-4720-bcce-2424a6d452e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ab3360d-6410-4c7a-a4d1-ecb05fbd1394" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08cbbc4f-f0be-4720-bcce-2424a6d452e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_876b82e3-9348-4570-94a6-a53a08a8a9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08cbbc4f-f0be-4720-bcce-2424a6d452e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_876b82e3-9348-4570-94a6-a53a08a8a9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9b826602-661b-4646-afe8-6343482b9175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08cbbc4f-f0be-4720-bcce-2424a6d452e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9b826602-661b-4646-afe8-6343482b9175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_732adab5-c310-48ce-b633-9b7327c13676" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08cbbc4f-f0be-4720-bcce-2424a6d452e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_732adab5-c310-48ce-b633-9b7327c13676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_da1e5be1-9a3b-4c9f-8830-9131c92715fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_08cbbc4f-f0be-4720-bcce-2424a6d452e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_da1e5be1-9a3b-4c9f-8830-9131c92715fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b1da2720-6c82-4927-9042-1bb4c99c45d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ab3360d-6410-4c7a-a4d1-ecb05fbd1394" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b1da2720-6c82-4927-9042-1bb4c99c45d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_ca0b91d7-8622-42bb-936e-221133c3c284" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ab3360d-6410-4c7a-a4d1-ecb05fbd1394" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_ca0b91d7-8622-42bb-936e-221133c3c284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d160b5d9-f586-45b2-b1b4-412b313722a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ab3360d-6410-4c7a-a4d1-ecb05fbd1394" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d160b5d9-f586-45b2-b1b4-412b313722a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_d8e74115-01a5-4616-bfd1-94baafebf383" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ab3360d-6410-4c7a-a4d1-ecb05fbd1394" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_d8e74115-01a5-4616-bfd1-94baafebf383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_10f6bfe0-fe54-4d2f-b492-f40694f17489" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ab3360d-6410-4c7a-a4d1-ecb05fbd1394" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_10f6bfe0-fe54-4d2f-b492-f40694f17489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_78b6f953-8e08-4d82-9228-96ebf5f2f911" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ab3360d-6410-4c7a-a4d1-ecb05fbd1394" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_78b6f953-8e08-4d82-9228-96ebf5f2f911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b35982cc-6d38-4b73-8756-5a49c432003f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ab3360d-6410-4c7a-a4d1-ecb05fbd1394" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b35982cc-6d38-4b73-8756-5a49c432003f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0c47159f-1e46-4d32-9e7b-3192701a885b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ab3360d-6410-4c7a-a4d1-ecb05fbd1394" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0c47159f-1e46-4d32-9e7b-3192701a885b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_a7658a6c-cdfc-4800-b411-ce26d0e91ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3ab3360d-6410-4c7a-a4d1-ecb05fbd1394" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_a7658a6c-cdfc-4800-b411-ce26d0e91ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/StockBasedCompensationRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="xfor-20240331.xsd#StockBasedCompensationRestrictedStockUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/StockBasedCompensationRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e6bcffe6-d547-4b2c-a320-329d176ea60e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f0582425-ea12-41d2-b5f6-aebea0c05d39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e6bcffe6-d547-4b2c-a320-329d176ea60e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f0582425-ea12-41d2-b5f6-aebea0c05d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2463be13-6058-4873-adb0-50687ac0fd31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f0582425-ea12-41d2-b5f6-aebea0c05d39" xlink:to="loc_us-gaap_AwardTypeAxis_2463be13-6058-4873-adb0-50687ac0fd31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e2f5b9a-69a9-4d0d-969b-dea11dbffaea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2463be13-6058-4873-adb0-50687ac0fd31" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e2f5b9a-69a9-4d0d-969b-dea11dbffaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_422a3352-3013-4629-91b2-c068c6854d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e2f5b9a-69a9-4d0d-969b-dea11dbffaea" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_422a3352-3013-4629-91b2-c068c6854d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03cb02b9-057c-4d3d-9f29-24cf40678fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f0582425-ea12-41d2-b5f6-aebea0c05d39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03cb02b9-057c-4d3d-9f29-24cf40678fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_111a1f91-30ac-4ac3-8290-ad0d2247b481" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03cb02b9-057c-4d3d-9f29-24cf40678fa0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_111a1f91-30ac-4ac3-8290-ad0d2247b481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cfabb6b6-8194-4632-b507-d226745fbb9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_111a1f91-30ac-4ac3-8290-ad0d2247b481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cfabb6b6-8194-4632-b507-d226745fbb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_83610840-00f1-43b3-ac93-50651ee08175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_111a1f91-30ac-4ac3-8290-ad0d2247b481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_83610840-00f1-43b3-ac93-50651ee08175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_48220179-b7d2-4f92-8224-4130efca41b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_111a1f91-30ac-4ac3-8290-ad0d2247b481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_48220179-b7d2-4f92-8224-4130efca41b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_24ad5a2f-dc4e-45ba-bb43-17281ee8784b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_111a1f91-30ac-4ac3-8290-ad0d2247b481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_24ad5a2f-dc4e-45ba-bb43-17281ee8784b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4e99c123-1503-4445-8a62-ec241514889b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_111a1f91-30ac-4ac3-8290-ad0d2247b481" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4e99c123-1503-4445-8a62-ec241514889b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseClassificationDetails" xlink:type="simple" xlink:href="xfor-20240331.xsd#StockBasedCompensationSummaryofStockBasedCompensationExpenseClassificationDetails"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseClassificationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bbe56b4b-4ee7-46d8-a043-fa16b494ef4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c8aeaa28-c0d4-47a2-9c38-8aaf2558a30f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bbe56b4b-4ee7-46d8-a043-fa16b494ef4b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c8aeaa28-c0d4-47a2-9c38-8aaf2558a30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a2cd0c86-d082-42ff-9b0d-7df513a47b07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c8aeaa28-c0d4-47a2-9c38-8aaf2558a30f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a2cd0c86-d082-42ff-9b0d-7df513a47b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_233031e1-0492-4668-a61d-eca442eb99fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a2cd0c86-d082-42ff-9b0d-7df513a47b07" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_233031e1-0492-4668-a61d-eca442eb99fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4dcf6514-5791-4f5d-9514-1dba8ba7b532" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_233031e1-0492-4668-a61d-eca442eb99fb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4dcf6514-5791-4f5d-9514-1dba8ba7b532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_cd5512c1-a18c-4022-a04a-99c692fc4ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_233031e1-0492-4668-a61d-eca442eb99fb" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_cd5512c1-a18c-4022-a04a-99c692fc4ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1889bf4c-2678-4763-b881-b78773e744fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c8aeaa28-c0d4-47a2-9c38-8aaf2558a30f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1889bf4c-2678-4763-b881-b78773e744fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_d87f8cbd-c1a0-4a2d-990c-f12fe1e6600b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1889bf4c-2678-4763-b881-b78773e744fe" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_d87f8cbd-c1a0-4a2d-990c-f12fe1e6600b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_373a926e-0793-4910-a778-c1fed7570eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ece30591-c0be-425e-a2a6-a531cf9b8165" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_373a926e-0793-4910-a778-c1fed7570eb1" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ece30591-c0be-425e-a2a6-a531cf9b8165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_c8196e95-3834-4da7-84c2-9783b92b2e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_373a926e-0793-4910-a778-c1fed7570eb1" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_c8196e95-3834-4da7-84c2-9783b92b2e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f3d5f35f-9fb4-4287-a002-c099efbfd603" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_373a926e-0793-4910-a778-c1fed7570eb1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f3d5f35f-9fb4-4287-a002-c099efbfd603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/NetLossperShareSummaryofBasicandDilutedNetlossperShareAttributabletoCommonStockholdersDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#NetLossperShareSummaryofBasicandDilutedNetlossperShareAttributabletoCommonStockholdersDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/NetLossperShareSummaryofBasicandDilutedNetlossperShareAttributabletoCommonStockholdersDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f174ba3a-a15a-45dd-9aef-747e85ab28d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_NumeratorAbstract_2d9fa0a1-9b73-4cf5-b47c-fc3d9009ca8e" xlink:href="xfor-20240331.xsd#xfor_NumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f174ba3a-a15a-45dd-9aef-747e85ab28d6" xlink:to="loc_xfor_NumeratorAbstract_2d9fa0a1-9b73-4cf5-b47c-fc3d9009ca8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4a14e84b-8e09-4739-b385-16af9fafe54d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_NumeratorAbstract_2d9fa0a1-9b73-4cf5-b47c-fc3d9009ca8e" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4a14e84b-8e09-4739-b385-16af9fafe54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_DenominatorAbstract_da6ce13c-4f0f-4e25-bea8-3c18d1399d7f" xlink:href="xfor-20240331.xsd#xfor_DenominatorAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f174ba3a-a15a-45dd-9aef-747e85ab28d6" xlink:to="loc_xfor_DenominatorAbstract_da6ce13c-4f0f-4e25-bea8-3c18d1399d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1e1e4b5d-79be-4c95-8415-58b5d46c2e04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_DenominatorAbstract_da6ce13c-4f0f-4e25-bea8-3c18d1399d7f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1e1e4b5d-79be-4c95-8415-58b5d46c2e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3a3f6904-3e74-4c6f-934f-6180f90479ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_DenominatorAbstract_da6ce13c-4f0f-4e25-bea8-3c18d1399d7f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3a3f6904-3e74-4c6f-934f-6180f90479ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8546c49d-c39f-4629-9e2d-e14f94fb251e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_DenominatorAbstract_da6ce13c-4f0f-4e25-bea8-3c18d1399d7f" xlink:to="loc_us-gaap_EarningsPerShareBasic_8546c49d-c39f-4629-9e2d-e14f94fb251e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0f5b06a6-265e-4625-b9f9-77cf56b58b10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_xfor_DenominatorAbstract_da6ce13c-4f0f-4e25-bea8-3c18d1399d7f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0f5b06a6-265e-4625-b9f9-77cf56b58b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/NetLossperShareAdditionalInformationDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#NetLossperShareAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/NetLossperShareAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_69b7128f-85c1-400d-8b66-60b1f12094aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_2eafdfb6-ae19-4e0f-8f85-b07fbb084bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_69b7128f-85c1-400d-8b66-60b1f12094aa" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_2eafdfb6-ae19-4e0f-8f85-b07fbb084bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c050938d-36d5-4bdc-97d9-14c275e63be7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_2eafdfb6-ae19-4e0f-8f85-b07fbb084bdd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c050938d-36d5-4bdc-97d9-14c275e63be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5779b8ff-48bc-4f5e-b75c-c62ba175c2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c050938d-36d5-4bdc-97d9-14c275e63be7" xlink:to="loc_us-gaap_EquityComponentDomain_5779b8ff-48bc-4f5e-b75c-c62ba175c2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_xfor_PreFundedWarrantMember_b57b3544-cc33-4f82-b51f-b6912ccec772" xlink:href="xfor-20240331.xsd#xfor_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5779b8ff-48bc-4f5e-b75c-c62ba175c2eb" xlink:to="loc_xfor_PreFundedWarrantMember_b57b3544-cc33-4f82-b51f-b6912ccec772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3e0fa339-cd53-4528-9d70-37a8f20517ac" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_2eafdfb6-ae19-4e0f-8f85-b07fbb084bdd" xlink:to="loc_srt_RangeAxis_3e0fa339-cd53-4528-9d70-37a8f20517ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_24493a74-728d-46f3-914f-2c0285dfd40d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3e0fa339-cd53-4528-9d70-37a8f20517ac" xlink:to="loc_srt_RangeMember_24493a74-728d-46f3-914f-2c0285dfd40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c1d11f1b-c261-425e-87ed-2d520e64e6b8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_24493a74-728d-46f3-914f-2c0285dfd40d" xlink:to="loc_srt_MaximumMember_c1d11f1b-c261-425e-87ed-2d520e64e6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_2f93db2c-a5e0-42c1-b776-85c755de0f29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_2eafdfb6-ae19-4e0f-8f85-b07fbb084bdd" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_2f93db2c-a5e0-42c1-b776-85c755de0f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_e42460e9-65e6-4e8f-8275-89cd1447cca8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_2f93db2c-a5e0-42c1-b776-85c755de0f29" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_e42460e9-65e6-4e8f-8275-89cd1447cca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.x4pharma.com/role/NetLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedNetLossperShareAttributabletoCommonStockholdersDetail" xlink:type="simple" xlink:href="xfor-20240331.xsd#NetLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedNetLossperShareAttributabletoCommonStockholdersDetail"/>
  <link:presentationLink xlink:role="http://www.x4pharma.com/role/NetLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedNetLossperShareAttributabletoCommonStockholdersDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a7185b6c-8c60-4e2c-9bcd-1d875b846665" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_611b50f7-6eae-4fe2-9c75-7c881205f1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a7185b6c-8c60-4e2c-9bcd-1d875b846665" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_611b50f7-6eae-4fe2-9c75-7c881205f1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_86bb8eec-d80f-432a-8078-1e95c9d3af56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_611b50f7-6eae-4fe2-9c75-7c881205f1b7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_86bb8eec-d80f-432a-8078-1e95c9d3af56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ceff04c-a6bc-490b-9106-98ee772e5d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_86bb8eec-d80f-432a-8078-1e95c9d3af56" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ceff04c-a6bc-490b-9106-98ee772e5d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0a00b4ee-f5ef-4274-aca5-c7e788ade22e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ceff04c-a6bc-490b-9106-98ee772e5d2b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0a00b4ee-f5ef-4274-aca5-c7e788ade22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_55838337-df9f-4ac6-9390-329547a36d67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ceff04c-a6bc-490b-9106-98ee772e5d2b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_55838337-df9f-4ac6-9390-329547a36d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_0a35f4c4-0dde-4472-a029-c6cfd63298de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ceff04c-a6bc-490b-9106-98ee772e5d2b" xlink:to="loc_us-gaap_WarrantMember_0a35f4c4-0dde-4472-a029-c6cfd63298de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0ca0329e-970c-4537-937e-5e61082fce01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_611b50f7-6eae-4fe2-9c75-7c881205f1b7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0ca0329e-970c-4537-937e-5e61082fce01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4267b19c-193a-4f54-bf22-32148d777d49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0ca0329e-970c-4537-937e-5e61082fce01" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4267b19c-193a-4f54-bf22-32148d777d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
